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Across Europe over the last two decades 
there has been a welcome reduction in the 
proportion of people having a stroke (when 
taking age into account)� And people’s 
chance of recovering from their stroke has 
greatly improved�   Europe boasts some 
of the best stroke care in the world, has 
pioneered important developments in the 
prevention and treatment of stroke, has an 
active stroke research community and has 
patient advocacy organisations in almost 
every country� 
But, despite this progress, the numbers 
of strokes are set to rise because the 
proportion of Europeans over 70 is 
increasing�  The projections in this report 
indicate that between 2015 and 2035, 
overall there will be a 34% increase in total 
number of stroke events in the EU from 
613,148 in 2015 to 819,771 in 2035�  Stroke 
prevention should, therefore, be a high 
priority� Despite most European countries 
having guidelines for risk factors such as 
high blood pressure and atrial fibrillation, 
there is significant under-treatment� And 
well below half of all people treated for high 
blood pressure, for example, are actually 
on enough medication to get their blood 
pressure below the desired target level�
While death rates from stroke have been 
falling over the last twenty years, your 
chance of dying from a stroke varies 
greatly according to where in Europe you 
live� Currently, rates of deaths from stroke 
in different countries range from 30 per 
100,000 of the population to 170 per 100,000 
of the population� Falling death rates due 
to better and quicker treatment mean that 
there will be more people surviving their 
strokes and living with the consequences� 
So the estimated total cost of stroke in 
Europe (healthcare and non-healthcare 
costs) of an estimated 45 billion euros in 
2015 is set to rise�
When it comes to stroke care, the inequalities 
across the continent are apparent�  For 
example, in some European countries we 
are concerned about how effective public 
education campaigns to encourage an 
emergency response to stroke are� But in 
many places across Europe emergency 
services specialised in stroke simply do not 
exist�  Thrombolysis (clot-busting treatment) 
rates vary from less than 1% of patients to 
16%�
Foreword
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Despite over thirty years of evidence 
showing the difference stroke units make, 
only about 30% of patients receive stroke 
unit care across Europe� The proportion 
of people who get treated on a stroke unit 
varies from less than 10% to over 80%, 
depending on where you live� Existing 
European Stroke Organisation guidelines 
are not consistently applied and a continent-
wide, evidence-based system of specialist 
stroke care is yet to be realised�
Access to rehabilitation and long-term 
support is also a significant issue in many 
parts of Europe� Provision of rehabilitation 
is not widely monitored in many parts of 
Europe and even where there are audits, 
people often receive therapies during only 
brief periods of each day in hospital� In 
several countries there is very limited access 
to therapies once people are at home� 
There are no outpatient therapy services in 
two out of every five EU countries�
SAFE commissioned the Burden of Stroke 
study to show each EU country where it 
stands in terms of the stroke burden and 
how well it is meeting the need for acute 
and follow-up care, including examples of 
good practice� The research findings for this 
report have led SAFE to generate a number 
of action points for EU policy makers, 
national health service representatives and 
stroke support organisations�
SAFE is a non-profit-making organisation 
that represents a range of stroke patient 
groups from across Europe whose mutual 
goal is to drive stroke prevention and care 
up the European and national political 
agendas, prevent the incidence of stroke 
through education and support stroke care 
and patient centred research� SAFE aims to 
raise awareness of the major impact stroke 
has on individuals and on the health and 
economy of Europe�
Jon Barrick, SAFE President
IntroduCtIon
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Background
Stroke is a brain attack, affecting 17 million 
people worldwide each year� It is the 
second most common cause of death[1] and 
a leading cause of adult physical disability[2]�
Stroke survivors can experience a wide 
range of outcomes that are long-lasting, 
including problems with mobility, vision, 
speech and memory; personality changes; 
fatigue; and depression[3, 4]� 
SAFE commissioned King’s College London 
to produce a white paper describing the 
burden of stroke globally for publication 
in 2007� At the time of writing that report, 
there was no up to date, comprehensive 
assessment of the numbers of people 
having stroke, dying from stroke or living 
with disability as a result of stroke in most 
European Union countries� Since then, a 
large global and regional study of these 
numbers has been undertaken as part of 
the Global Burden of Diseases, Injuries, and 
Risk Factors Study[5]� The present study uses 
the most recent available data to describe 
stroke epidemiology, prevention and care 
across the EU�
Scope of the study and methods
In order to frame the study and enable 
comparisons across countries and regions, 
SAFE required the inclusion of a number of 
indicators of stroke care quality� There are 
potentially many such indicators that could 
have been included; to keep the study 
manageable in the available time, a shortlist 
of 12 indicators was chosen (Appendix 2�1) in 
discussion with colleagues at King’s College 
London and SAFE to reference different 
parts of the stroke care ‘pathway’, from 
prevention to long-term care and support� 
Information on these indicators and the 
epidemiology of stroke in each country was 
gathered through reviewing the scientific 
literature and by consulting with stroke 
researchers, clinicians and stroke support 
organisation representatives� 
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Structure of the report 
The report is structured to reflect the stroke 
care pathway, and focuses on the 12 stroke 
care quality indicators� Each chapter starts 
with a brief, accessible introduction to the 
content� 
Chapter 1 describes variations across 
Europe in the number of people who have 
strokes, and explains some of the key 
terminology and data sources� It estimates 
the future epidemiological picture for stroke 
in Europe� 
Chapter 2 focuses on stroke prevention� 
It considers the provision of educational 
campaigns for the public, and describes how 
well (or inadequately) important stroke risk 
factors are being managed at population 
level�
Chapter 3 focuses on stroke as a medical 
emergency� It summarises evidence 
from different European countries of the 
level of public awareness of acute stroke 
symptoms, the existence of relevant training 
for healthcare professionals, and the impact 
of pre-hospital notification systems� 
Chapter 4 describes the availability of 
organised acute stroke care, i�e� stroke 
unit care, and delivery of thrombolysis� 
It highlights the significant variation in 
availability and standardisation of stroke 
unit care across Europe, and explores some 
of the barriers to delivering thrombolysis�
Chapter 5 summarises the available 
data on hospital-based and community 
rehabilitation in the different countries, and 
longer term support for stroke survivors and 
their families from statutory and voluntary 
agencies� 
The Recommendations section consolidates 
a number of action points proposed by SAFE 
board members, based on the evidence 
in this report and prioritised according to 
the advocacy interests of SAFE’s member 
organisations�
A summary of stroke epidemiology 
and data on the 12 stroke care quality 
indicators is provided for each EU and SAFE 
member country in a separate publication 
(see www�strokeeurope�eu)�  
reCoMMendAtIons
reCoMMendAtIons
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SAFE’s call to action to EU policy makers
The inequalities in stroke risk and stroke 
provision across Europe revealed in this 
report should be of great concern to 
European policy makers, especially as we 
predict a 34% rise in the number of people 
having strokes by 2035�  SAFE wants a 
Europe where everyone has the opportunity 
to prevent a stroke, and those who do have 
a stroke get treated as quickly as possible 
in a stroke unit; get the assessment and 
rehabilitation they need to maximise their 
recovery; and get the long term support 
they need to regain as much independence 
as possible� And we are concerned that 
the lack of unified data on stroke events 
and outcomes in Europe is a barrier to 
comparing stroke care both within and 
between different healthcare systems and, 
therefore, to improving stroke care� 
SAFE believes that each EU member state 
should have a national stroke strategy 
actively supported and sponsored by 
Government that covers the whole stroke 
pathway to include awareness, prevention, 
diagnosis, treatment, transfer of care, 
specialist rehabilitation and reassessment, 
long-term care and support, social 
integration and participation in community 
life and end-of-life care� Representatives 
from the wide range of professionals who 
support people with stroke, people who 
have had a stroke, carers and voluntary 
associations should all be involved in 
creating such strategies�
© Can Stock Photo / paulgrecaud
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Facilitate coordinated, Europe-wide data collection� In particular, the European Commission 
and the Joint Research Centre should support and promote the use of a robust Europe-wide 
stroke register including instruments to assess needs for prevention and care as well as the 
quality of care along the whole stroke pathway�
Incorporate the stroke indicators used in this report (e�g� blood pressure management, 
door-to-needle time, coordinated discharge and post-discharge rehabilitation assessment) 
in the EU’s work on the evaluation of the performance of health systems, as they are good 
measures to assess the efficiency of care organisation and delivery in member states�
Support, together with Member States, a Joint Action on stroke, in the framework of the 
EU Health Programme� The Joint Action should focus on addressing the following topics: 1) 
data collection, 2) prevention, 3) promotion and implementation of national stroke strategies, 
and 4) performance assessment�  Stroke Support Organisations (SSOs) should be actively 
involved in the Joint Action, and their crucial role throughout the stroke pathway, and in 
policy formation, should be enshrined in the national stroke strategies�
Support research into patient-reported experience, outcome measures and quality of life 
across Europe�  This is linked to the need for more research on long-term management 
and support so that best practice and the effectiveness and cost-effectiveness of different 
models can be identified� SAFE believes strongly that patients and patient organisations/
SSOs should be actively involved in these studies as participants and co-researchers and 
that building the capacity for their participation is also vital�
therefore, sAFe calls on eu policy-makers (Commission, Parliament, Council) to:
The Burden of Stroke in Europe
10
What needs to change
The evidence in this report highlights improvements that 
are needed across the whole stroke care pathway� The 
wide disparities in provision between countries and the 
inequalities within countries found in this report should 
be of concern to all European policy makers as well as 
to national Governments and health planners�
The burden of stroke
There is a lack of unified data about stroke and stroke 
outcomes� Europe-wide comparisons of stroke and 
stroke care are vital to help each country prevent stroke 
and provide better care and support for everyone 
affected by stroke� To make accurate comparisons 
between different countries, populations and health 
systems we need agreed and coordinated Europe-wide 
data collection� Therefore, European policy-makers, 
in particular the European Commission and the Joint 
Research Centre, should support and promote the use 
of a robust Europe-wide stroke register to assess quality 
of care along the whole stroke pathway�
The number of people having a stroke and the number 
of people living with the long-term effects of stroke 
will rise in the coming decades�  Effective health care 
planning and adequate resource allocation across 
Europe is needed to deal with this, taking into account 
that the financial burden of stroke is to a large extent 
borne by stroke survivors themselves and their families�
There are limitations to the current research evidence 
from the perspective of European stroke survivors (for 
example, it is largely based on small studies from mostly 
Western European countries)� This research should 
be conducted more widely throughout Europe, and 
consolidated findings should be used to influence patient 
care� SAFE believes that these studies should actively 
involve stroke survivors and patient organisations� 
© MisitaPR
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Preventing stroke
A more systematic, evidence-based approach to public education 
across the EU is required to improve knowledge of the modifiable 
risk factors for stroke, i�e� an awareness that those risk factors 
significantly increase the risk of stroke but can be treated in most 
cases� Joining forces with public education efforts in relation to 
the other cardiovascular diseases could create a more powerful 
message and greater impact�
Current educational campaigns should be assessed for their 
effectiveness� Our understanding needs to go beyond measuring 
public knowledge and awareness to look at the extent to which 
they positively influence public behaviour over time� We should 
build on what works and make sure public education is both 
effective and cost effective� Innovative campaigning methods 
(such as: the use of social media, apps; collaborative campaigns in 
co-operation with other medical specialties; risk factor education 
in schools; and risk-factor checks in places such as workplaces or 
pharmacies) should be assessed�
Across Europe we need rapid and concerted action to prevent 
stroke and, especially, improvement in the detection and treatment 
of high blood pressure (hypertension) and atrial fibrillation (AF, an 
abnormal heart rhythm with rapid and irregular beating)� Medical 
professionals and patients must both be involved through shared 
decision-making, in order to increase adherence to existing 
guidelines, and compliance with prescribed medications and 
frequent blood pressure checks� 
Improvement in the diagnosis and management of AF is needed 
including systematic approaches to identifying and monitoring AF� 
The effectiveness and cost-effectiveness of AF screening policies 
of at-risk populations should be assessed in the respective health 
contexts of each country, as do new developments such as 
devices and apps for detecting AF, self-monitoring of INR, and 
new anti-coagulation therapies� A more systematic approach to 
monitoring guideline adherence (e�g� national or large regional 
audits), and possibly incentivising this adherence might improve 
treatment rates�
Timely assessment of suspected TIA patients in specialist clinics 
should be widely available�
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Stroke as a medical emergency
SAFE calls for continuous and sustained awareness-raising 
campaigns across Europe so that more people understand 
stroke symptoms and treat stroke as a medical emergency� 
These should be included in national stroke strategies, financially 
supported by Governments and should include stroke survivors 
in their planning and implementation�
We need to know which public education campaigns across 
Europe have worked best, and why, so that success can be 
replicated� Systematic assessment of public health campaigns 
undertaken across Europe is required to prove their effectiveness 
and improve their impact� More collaborative working with 
voluntary sector organisations might improve the impact of 
campaigns� 
There should be a more systematic approach towards training 
healthcare professionals, using evidence-based methods and on-
going assessment of its implementation and effectiveness� 
There is a need to improve emergency pathways in some 
centres in order to reduce Door-To-Needle times�  Strategies will 
depend on the respective national, regional, and local health 
infrastructure�
Acute care
There are still far too few people across Europe being treated in 
dedicated stroke units with stroke specialist, multidisciplinary staff� 
Efforts are required, especially in Eastern European countries, but 
also many Western European areas, to increase the availability of 
stroke unit care and personnel specialised in stroke care�
Improvement plans should prioritise the consistent implementation 
of key elements of organised stroke unit care, as laid out in 
European Stroke Organisation (ESO) and national guidelines�
Comparisons of stroke unit care between European countries are 
difficult� Standardised, Europe-wide assessment criteria for stroke 
unit care would encourage international benchmarking and could 
drive quality improvement�
© Stroke Association
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Thrombolysis is still under-performed across all of Europe� 
Structural changes to acute stroke care within the respective 
national and local context could help to improve thrombolysis 
rates and patient outcomes�
Thrombectomy is currently unavailable to the majority of 
European stroke patients� Organisational changes are required 
with hospital networks and regional referral centres in order to 
facilitate the implementation of thrombectomy across Europe and 
to make it more widely available�
Rehabilitation and long term support
Too many stroke survivors have to wait too long to get an 
assessment of their rehabilitation needs and to actually receive 
therapy� Across Europe the aim should be for multi-disciplinary 
assessments to take place on the stroke unit, and for rehabilitation 
to start as soon as someone is medically stable�
Access to rehabilitation therapy must be improved� There is a 
particular lack of occupational, speech and psychological therapy 
across Europe�
Too many stroke survivors leave hospital without on-going 
rehabilitation being in place� This is of particular concern for 
Early Supported Discharge (ESD) schemes� The evidence is clear 
that the effectiveness of ESD schemes relies upon access to 
rehabilitation at the same intensity as would have been provided 
on the stroke unit�  
Ongoing, long-term support and follow up is inadequate in many 
parts of Europe�  We call for national systems to be developed to 
ensure stroke survivors’ needs are reviewed and followed up�
Countries should set targets for secondary prevention, screening 
for depression, and for psychological and social support�
© Can Stock Photo / dolgachov
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the burden of stroke
the rate of new strokes and stroke deaths, 
when adjusting for age, has decreased 
over the last two decades in all European 
countries� Decreasing rates of new strokes 
are generally attributed to successful 
prevention strategies, e�g� hypertension 
control and smoking cessation� On average, 
improvements have been larger in Western 
European countries - increasing the already 
existing difference between East and West�
However, due to the ageing of the European 
population and the strong association 
between stroke risk and age, the numbers 
of people having a stroke continues to 
rise� Using data from the Global Burden 
of Disease study 2015, and demographic 
projections obtained from Eurostat 
(statistical office of the EU), a 34% increase 
in total number of stroke events in the EU 
between 2015 and 2035 is predicted�
Together with the welcome improvement in 
survival rates, there are increasing numbers 
of people living with the effects of stroke, 
needing specialist supportive care and 
rehabilitation, resulting in a growing burden 
of stroke on families, societies and health 
care systems� 
In 2015, direct healthcare costs alone added 
up to €20 billion in the EU, while indirect 
costs of stroke due to the opportunity cost 
of informal care by family and friends and 
lost productivity caused by morbidity or 
death were estimated to be another €25 
billion� Reducing the incidence of stroke 
and the likelihood of long-term disability will 
help to bring down these costs[6, 7]�
Preventing stroke
Stroke is preventable, but public knowledge 
about the risk factors for stroke is low� The 
impact of educational campaigns aiming to 
change behaviour is largely short-lived� 
The proportion of the population with one 
or more risk factors for stroke is significant� 
High blood pressure, the most important 
risk factor for stroke, is significantly 
under-treated� The proportion of people 
with known high blood pressure who 
achieve adequate blood pressure control 
is well below half� Atrial fibrillation (AF, 
an abnormal heart rhythm with rapid and 
irregular beating), another important risk 
factor, is often not diagnosed until after a 
stroke event, or not treated according to 
widely available, national, evidence-based 
guidelines�
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emergency care
In stroke care, “time is brain”: patients with 
suspected stroke need to be admitted to 
hospital wherever possible, assessed and 
treated as appropriate within a few hours, 
to improve their outcomes� However, 
public awareness of stroke as a medical 
emergency is poor� An international 
European study showed that about one in 
five people could not identify any stroke 
symptoms and only about half would call an 
ambulance� Many educational campaigns 
are being undertaken, but most are not 
systematically evaluated for their impact�
Similarly, in most European countries there 
is no evidence that training of medical 
staff involved in emergency stroke care is 
implemented and monitored systematically� 
Many regions have improved their pre- 
and in-hospital emergency care pathways� 
There is an opportunity to learn from these 
experiences and try to replicate them 
elsewhere�
stroke units
Improvements in survival have been made 
particularly since the implementation 
of stroke units and thrombolysis (clot-
busting) treatment� There have been 
significant increases in the number and 
quality of stroke units in Europe� However, 
despite their inclusion in European and 
national guidelines, it is estimated that only 
about 30% of european stroke patients 
receive stroke unit care� Variations between 
countries, but particularly also between 
different areas within countries, are large� 
Rural and remote areas often have poor 
access� 
In order to improve the quality of care 
received in stroke units, internationally 
agreed standards of stroke unit care 
based on evidence and expert opinion 
have been developed� A system of official 
accreditation has been introduced on a 
European level, and also national level in 
several countries, but uptake is very variable 
as it is mostly voluntary�
The benefit of thrombolysis is well 
established� However, thrombolysis rates 
are still significantly below expectations� 
Barriers to the delivery of thrombolysis are 
numerous and complex, depending on the 
local context: pre-and in-hospital delays, 
a lack of specialised units or staff, lack of 
diagnostic equipment, insufficient funding, 
and decentralised systems of stroke care 
have all been linked to lower thrombolysis 
rates�
@
S
ta
rl
in
e
 /
 F
re
e
p
ik
The Burden of Stroke in Europe
17
rehabilitation and supporting 
longer-term needs
For many countries, there is very little 
information on the rehabilitation therapies 
that stroke survivors receive, especially 
once they have left hospital� Few countries 
audit rehabilitation services, and there are 
inconsistencies in the standards used to 
measure adherence to guidelines across 
Europe�
The type and quality of therapies that 
patients can access often depend on 
where they live� For example, specialist 
rehabilitation may only be available in large 
urban areas� Occupational therapy and 
psychological support are either very limited 
or not available at all to stroke patients in 
several countries� Patients can experience 
long delays in starting rehabilitation 
because of a lack of capacity in rehabilitation 
centres or in the community� 
Once patients have been discharged from 
acute care, access to further rehabilitation 
is also very variable between and 
within countries� In around two in five EU 
countries, outpatient therapies are not 
generally available� Only a small minority 
of EU countries have local arrangements 
to offer stroke survivors a follow-up review 
with a therapist or doctor, and again, actual 
practice can vary substantially within a 
country�   
Health insurers and national health 
authorities rarely offer support with 
adjusting to life after stroke, such as 
programmes to support people who want 
to return to work. In the last 5-10 years 
most European countries have cut funding 
of some services that support disabled 
people, such as training that helps people 
return to work�
stroke support organisations (ssos) exist 
at a national level in nearly all eu countries. 
They aim to offer practical, emotional and 
advocacy support for stroke survivors and 
their families and, often, promote stroke 
prevention awareness and action� There is 
a need for more information on the reach 
and impact of SSOs�
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Indicators
In order to frame the study and enable comparisons across countries and regions these 
indicators were chosen in discussion with colleagues at King’s College London and SAFE to 
reference different parts of the stroke care ‘pathway’, from prevention to follow-up care and 
support�  
Indicator
Report 
section 
1� Campaigns to encourage healthy lifestyles (e�g� blood pressure and 
cholesterol awareness and monitoring)
2�1 
2� Blood pressure is checked regularly and treated according to 
guideline 
2�2 
3� Adults with atrial fibrillation at increased risk of stroke are treated 
appropriately with anticoagulants 
2�3  
4� Public campaigns and professional education emphasise that stroke 
is a medical emergency
3�1 and 3�2 
5� Emergency services (ambulance) staff are trained to screen patients 
for suspected stroke/TIA and arrange immediate transfer to hospital
3�2 
6� In-hospital services offer organised stroke care (stroke unit care) 4�1 
7� Patients are assessed for thrombolysis and receive it (if clinically 
indicated) as soon as possible after the start of stroke symptoms
4�2 
8� Patients with suspected TIA are urgently assessed for subsequent 
stroke risk
2�4 
9� Patients are assessed for rehabilitation needs within the first 
three days after admission and provided with rehabilitation by 
multidisciplinary staff on the basis of need
5�3 
10� Early discharge from acute care (to inpatient rehabilitation unit or to 
community) is supported for medically stable patients with mild or 
moderate impairment
5�4 
11� Patients are offered a review after the stroke for assessment of 
medical and rehabilitation needs
5�5 
12� Patients and their family/carers have access to practical and 
emotional support
5�7 
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This section outlines the number of strokes, deaths from stroke, and people living with stroke 
across Europe�  It includes predictions about what the burden of stroke will be in 2035 and 
looks at the financial and societal cost of stroke�
1.1 What is being measured?
It is important that we have reliable 
information about the number of people 
across Europe who have a stroke and 
what happens to them�  What services and 
support do they get? To what extent do they 
recover? How well are health and social 
services doing and how do we improve 
outcomes? What is the economic impact of 
stroke on individuals and also on society? 
What resources are needed to make sure 
everyone who has a stroke gets the help 
they need?
The way that information about stroke is 
gathered varies widely across Europe and 
there are pros and cons about different sets 
of information� National stroke registers 
and audits (e�g� in Austria, Denmark, 
Finland, Germany, Hungary, Ireland, Israel, 
Poland, Sweden, UK)[8] are a rich source 
of information but generally only pick up 
hospitalised patients�  So, for example, 
while 85% of cases are picked up in this 
way in Finland, Sweden and Denmark; in 
Poland less than 40% of stroke patients are 
included�
“While I was having a shower I suddenly felt 
like something had exploded in my head. I 
was not able to speak any more and I felt like 
the right side of my body had disappeared.” 
(Female stroke survivor, 
Netherlands)
example from estonia: Three stroke audits have been initiated by the Estonian 
Health Insurance Fund in 2003, 2010 and 2013 aiming to analyse acute stroke 
management in Estonia. Approximately one percent of all annual stroke cases have 
been randomly selected from all (18) hospitals. 5 experts using a unified protocol 
have reviewed medical documents. Neurologists from the Estonian L. Puusepp 
Society of Neurologists and Neurosurgeons have conducted the audits. Feedback 
has been given to all health care providers and the results have been published in 
the national medical journal “Eesti Arst”.[9]
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Population based registers, looking only 
at a smaller geographical area, overcome 
this problem by including reports from 
general practitioners (GPs) and outpatient 
departments, for example, and also have 
the advantage of providing the potential 
to measure the longer term outcomes of 
stroke survivors�
For this report, various types of data have 
been used� Most studies differ in their 
epidemiological and statistical methods, 
so comparing between them has to be 
done carefully� This report aims to present 
the most comparable data from different 
countries in order to show trends across 
Europe�
the most common measures used are: 
Incidence – the number of new strokes. 
The incidence of stroke depends on risk factors that can’t be changed, such as age, and risk 
factors that are modifiable, such as high blood pressure or smoking� The number of people 
having a stroke is, therefore, influenced by prevention measures�
Mortality – the number of people who die as a result of their stroke. 
This is linked to how severe someone’s stroke is, but also to the quality of stroke care, 
particularly acute stroke care� Measuring “case fatality” (the number of stroke deaths within 
a month of having the stroke), is strongly linked to the provision of emergency and acute 
stroke care�
Prevalence – the number of stroke survivors in the population. 
The number of stroke survivors captures stroke as a long-term condition and points to the 
level of rehabilitation needs that should be met�
Disability Adjusted Life Years lost (DALYs lost): 
combines morbidity (the number of years lived with a certain level of disability) and mortality, 
thereby estimating the number of healthy life-years lost in a population due to an illness�  It is 
useful for measuring the long-term societal burden of stroke�
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1.2 Incidence – how many people 
have a stroke?
There is great variation in the reported 
number of strokes as a proportion of the 
population between different studies�  Some 
of the variation is due to real differences 
in stroke incidence between different 
countries and regions�  But some of this 
variation is also due to the different criteria 
and methods used to collect the data� 
Despite this some trends do emerge�
Table 1 shows that there are major 
differences in stroke incidence rates across 
Europe� Some of the highest rates are in 
Eastern and Northern Europe (Croatia, 
Estonia, Lithuania, Sweden); and some of 
the lowest are in Western and Southern 
European countries (France, Italy, Spain)�  
This is similar to findings from the European 
Registers of Stroke project[10]� Large 
variations in incidence are also seen within 
countries (e�g� Italy, Spain, Sweden, UK)� 
Possible explanations for these large 
inter- and intra-country differences include 
different risk factor profiles (e�g� high 
blood pressure or cholesterol, smoking, 
diet, alcohol, exercise), socio-economic 
and environmental factors (air pollution, 
deprivation), but also standards of and 
access to healthcare, leading to different 
levels of risk factor control, and of acute and 
long term care�
”I never had before 
thought about that 
disease; I had no way 
of [knowing], nobody 
in the family had ever 
had a stroke. I thought 
everything was fine, 
and I was relatively 
young. I was 47.” 
(Female stroke survivor, 
Austria)
so, what do the data show?
@Benzoix - Freepik�com
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table 1: Annual incidence rates of first-ever stroke since 2000 reported by population-
based registers in European/SAFE countries, ranked by magnitude of incidence
Country / Region or 
town
Study 
period
Incidence rate standardised 
to the population of
sweden / Orebro[11] 1999-2000 254 Europe
Lithuania / Kaunas[10] 2004-2006 239 ♂, 159 ♀ Europe
Croatia / north-west area[12] 2007-2009 224 Europe
Portugal / Porto[13] 2009-2011 203 Portugal
estonia / Tartu[14] 2001-2003 188 Europe
Portugal / Porto[15] 1998-2000 181 Europe
Iceland[16] 2007-2008 177 England & Wales
uK / Oxford[17] 2002-2004 162 England & Wales
Italy / Sicily[18] 1999-2000 154 Europe
Italy / Puglia[19] 2001-2002 150 Europe
uK / South London[20] 2007-2010 150 England & Wales
spain / multi-centre[21] 2006 147 Europe
Germany / Ludwigshafen[22] 2006-2007 146 Europe
sweden / Lund-Orup[23] 2001-2002 144 Europe
Poland / Warsaw[10] 2005 147 ♂, 126 ♀ Europe
Poland / Zabrze[24] 2006-2006 131 Europe
Italy / Valley d’Aosta[25] 2004-2005 126 Europe
Germany / Erlangen[26] 2009-2010 127  ♂, 117  ♀ Europe
Ireland / North Dublin[27] 2006 118 World
spain / Menorca[10] 2004-2006 116 ♂, 66   ♀ Europe
uK / Scotland[28] 1998-2000 110 World
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table 1: continued
Country / Region or town
Study 
period
Incidence rate standardised 
to the population of
France / Dijon[29] 2000-2006 107 Europe
Italy / Udine[30] 2007-2009 104 Europe
Italy / Siesto Fiorentino[10] 2004-2006 101 ♂, 63   ♀ Europe
France / Brest[31] 2010 84 World
Italy / Valley d’Aosta[32] 2004-2008 80 World
Measuring stroke incidence or fatality 
over time can help to evaluate the impact 
of changes in prevention and acute care� 
For example, in Portugal falling incidence 
rates and improved stroke outcomes 
in two register periods correlated with 
changes in national stroke prevention and 
treatment strategies[13] (Table 2)� Stroke 
fatality declined in Zagreb (Croatia) after 
the introduction of stroke unit care[33] 
(Table 3)�
Table 2 shows that overall there has 
been a significant reduction in the age 
standardised rate of stokes since 1980� 
This trend has been noted for high-income 
countries in other studies� Population-
based registers reported an average 
decrease in stroke incidence of 42% in 
those countries (from 163/100,000 in 1970-
9 to 94/100,000 in 2000-8, standardised 
to the world population), compared to a 
52% increase in low and middle-income 
countries[34]� The assumption is that the 
fall is due to implementing successful 
risk reduction programs such as tobacco 
control and managing hypertension�
Created by Freepik
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table 2: Annual incidence and case fatality rates (at 1 month) in population-based registers 
in europe, ranked by falling, stable, or rising incidence rates
Country /Region 
or town
Population 
standardised 
to
Study 
period
Incidence rate per 
100,000, or trend 
Case fatality
Portugal / Porto[13] Portugal 1998-2000 261 
2009-2011 203 
uK / Oxford[35] England & 
Wales 
1981-1984 227 17�8%
2002-2004 162 17�2% 
uK / London[20] England & 
Wales 
1995-1998 247 25�4% (not published)
14�0% (not published)
2007-2010 150 
Germany / 
Erlangen[26]
Europe 1995-1996 176 ♂, 130 ♀
2009-2010 127 ♂, 117 ♀
estonia / Tartu[36, 37] Europe 1991-1993 230 30%
2001-2003 188 26% 
Finland / Turku[38] 1982-1992 Trend -1�8% Trend:
-3�8% ♂, -4�5% ♀ 
Italy / Valley 
d’Aosta[25, 32]
Europe
World
1989 177 31%
2004-2005 126 19%
2004-2008 100 16%
Lithuania / Kaunas[39] 1986-2012 Flat trend in 
first-ever strokes, 
increase in 
recurrences
Trend for 
ischaemic 
stroke:
-4�0% ♂, -6�0% ♀ 
denmark / 
Fredericksberg[40]
World 1972-1974 85 
1989-1990 106 
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table 2: continued
Country /Region 
or town
Population 
standardised 
to
Study 
period
Incidence rate per 
100,000, or trend 
Case fatality
France / Dijon[29, 41] Europe 1985-1989 81 17�8% 
2000-2006 107 10�0% (2000-
2004)
sweden / Lund-
Orup[23] 
Europe 1983-1985 134 15�4% 
1993-1995 158 15�4% 
2001-2002 144 14�3% 
Poland / Warsaw[42] Europe 1991-1992 111 43% 
2005 129 14�9%
Some long-running stroke registers 
have reported increasing incidence 
rates� Better diagnosis and case 
ascertainment due to the increasing 
use of radiological scans are possible 
explanations as well as still insufficient 
prevention efforts[39]�
@Kjpargeter - Freepik�com
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1.3 Case fatality – how many deaths are caused by stroke?
Case fatality, the mortality due to stroke within the first month, is an important measure of the 
severity of stroke and, importantly, acute care� 
Table 2 and 3 show wide variations in stroke fatality between countries as well as within 
countries e�g� between hospitalised and non-hospitalised patients (Ukraine[43]) or urban 
and rural populations (Bulgaria[44], Portugal[15])� Comparisons are limited because some of 
the reported rates date further back than others or refer to slightly different stroke patient 
populations�
table 3: Case fatality rates reported in european studies, ranked by magnitude of fatality 
rate
Country / Region or 
town
Study 
period
Case fatality rate
Bulgaria / Varna[44] 2000-2001 35% (aged 45-85, 48% for rural 
population)
uK / East Lancashire[45] 1995 34% 
Italy / Belluno[46] 1992-1993 33% 
Greece / Arcadia[47] 1993-1995 27% 
estonia / Tartu[14] 2001-2003 26% 
Italy / Sicily[18] 1999-2000 24% 
Italy / Vibo Valentia[48] 1996 24% 
Croatia / North-West[12] 2007-2009 24% 
ukraine / Uzhgorod[43] 1999-2000 23% (15% hospitalised, 
37% non-hospitalised)
Ireland / North Dublin[27] 2005-2006 21% 
Italy / Udine[30] 2007-2009 21%
Germany / Erlangen 1994-1996 19�%
norway / Innherred[49] 1994-1996 19% 
sweden / Orebro[11] 1999-2000 19% 
Poland / Zabrze[24] 2005-2006 18% 
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table 3: continued
Country / Region or 
town
Study 
period
Case fatality rate
Italy / Puglia[19] 2001-2002 18% 
Iceland / Reykjavik[50] 1996-1997 17% (hospitalised only)
Hungary, romania, ukraine / 
Mures-Uzhgorod-Debrecen[51] 
Not 
reported
16% ♂, 17% ♀ (hospitalised only)
uK / Scotland[28] 1998-2000 16%
Hungary / Debrecen[52] 1994-2006 15% (hospitalised only)
Portugal / Porto[15] 1998-2000 15% in rural areas, 16�9% 
in urban areas 
sweden / national audit[53] 2010 14% (hospitalised only, 84-92% 
hospitalised rate)
Finland / national audit[54] 1999-2007 14% (hospitalised only, 95-98% 
hospitalised rate)
uK / national audit[55] 2015/16 14% (hospitalised only)
Germany / Ludwigshafen[22] 2006-2007 14% 
Croatia / Zagreb[33] 2001-2006 13%, was 20�% in 1995-2000 
(hospitalised only, before and after 
introduction of stroke units)
The Organisation for Economic Co-operation and Development (OECD) 
(http://stats�oecd�org,[56]) released hospital-based case fatality rates for several European 
countries� Figure 1 shows those fatality rates stratified by stroke subtype� These rates are 
generally lower than those listed in table 2 and 3, which could be due to referring to data 
from more recent years, but also to only including hospitalised patients� Although not many 
Eastern European countries are included in this dataset, an East-West difference seems to 
emerge�
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Figure 1: Case fatality rates per 100 discharges (adults ≥45 years, age- and sex-adjusted, 
2009-11)
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Over the last few years, stroke fatality 
rates have generally improved, as reported 
in hospital-based and population-based 
studies (Table 2 and 3,[56])�  This could be due 
to people having less severe strokes; better 
risk factor control; and also as a result of 
earlier and more intensive acute treatment� 
There are significant inequalities in fatality 
rates across Europe and SAFE member 
countries� The vast majority of fatality rates 
reported from population-based registers 
are significantly higher than the target set in 
the Helsingborg 2006 declaration[57], which 
states that by 2015 85% of stroke patients 
should survive the first month� More up-
to-date rates are needed from population-
based registers to compare the current 
situation against the Helsingborg target� © Can Stock Photo / 4774344sean
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1.4 Prevalence – how many people are living with the consequences of stroke?
Stroke prevalence rates describe the number of people in a society with potential rehabilitation 
and secondary prevention needs due to their stroke� Prevalence studies are relatively rare 
compared to incidence studies and rely on door-to-door surveys or survey questionnaires 
with widely varying cooperation rates� Table 4 lists prevalence studies in Europe published 
since 2000�
table 4: european prevalence studies
Country
Study 
period
Method of case 
ascertainment
Stroke prevalence 
estimate
Croatia[58] 2005 Door-to-door survey 2�0% 
Finland[54] 2008 National stroke 
database
1�5% 
Germany[59] 2001 Population survey 
questionnaire
4�5% (aged ≥50 years)
Italy[60] 2004 Questionnaire & 
medical records
1�5% 
Italy[61]  2001 Door-to-door survey 8�2% ♂, 5�1% ♀
(aged ≥65 years)
netherlands[62] 2000 GP data 0�8% 
(estimate: 0�9% in 2020)
slovenia[63] 2001 National survey 0�9% (aged 25-64 years)
spain / Madrid[64] 1994 Screening 
questionnaire 
& neurological 
assessment
3�4%  
spain[65] 1991-
2002
Door-to-door survey 6�4% (aged ≥70 years)
sweden[66] Not clear Hospital data & self-
reports
18�8% (aged ≥85 years)
uK[67] 1995-
1996
GP data 0�9% 
Together with an ageing population and improving survival rates[68-72] the number of stroke 
survivors in Europe is rising[62]� This represents an increasing challenge for those trying to 
meet long term needs of stroke survivors, impacting on health and social care providers and 
their funders, as well as on families and other informal care givers�
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1.5 Disability-adjusted Life Years Lost
The concept of DALYs lost was developed 
as a combined measure of mortality (years 
of life lost) and morbidity (years lived with 
disability)� It captures the burden of a long-
term health condition, ranging from mild 
ill health to premature death, in a single, 
summary metric on a national or regional 
level, for example useful for estimating the 
societal cost of stroke (healthcare cost, 
formal and informal care costs, productivity 
lost)� Country-level DALY estimates are very 
rare, as the data necessary for calculation are 
difficult to collect and significant estimations 
are needed� One recent study estimated 
that cerebrovascular disease generated 
1,113 DALYs per 100,000 in Spain in 2008, 
but points out the significant variations in 
result depending on different estimates[73]� 
DALYs lost is widely used for international 
comparisons in the Global Burden of Disease 
study (Chapter 1�5)�
1.6 The Global Burden of Disease (GBD) Study
To overcome the problem of poor 
comparability between studies, the GBD 
study, a global research programme 
involving hundreds of experts worldwide, 
has developed statistical methods (multi-
state models implemented in the software 
program DisMod III) to model and calculate 
age-specific estimates of incidence, 
prevalence, mortality, and DALYs lost� While 
the study relies on some assumptions to 
deal with incomplete or low quality data, 
the estimates from GBD are widely used in 
stroke publications�
The latest edition was published 
as Global Burden of Disease Study 
2015 (GBD 2015)[74] (data available at: 
http://ghdx�healthdata�org/gbd-2015)� 
“I got the privileged service 
from the insurance; they 
wanted me to come back to 
work, so they invested in me. 
And this is today’s problem; 
they don’t do it any longer 
[i.e. invest in rehabilitation], 
and that is why I am fighting 
for the patients, because I 
received such good help and 
I am now really in a good 
shape.” 
(Female stroke survivor, 
Austria)
“The challenges [for stroke 
survivors and families in 
Greece] are day to day 
living …. But also, it is 
becoming a viable member 
of society again and I think 
that’s important worldwide, 
not only in [my country] 
Greece.” 
(Stroke clinician and stroke 
support organisation 
volunteer, Greece)
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Figure 2 shows GBD 2015 national estimates for incidence, prevalence, mortality and DALYs 
lost in 1995 and 2015�
Figure 2: number of new strokes and stroke survivors per 100,000 inhabitants in 1995 
and 2015 (age- and sex-standardised to the world standard population, GBd 2015)
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Figure 2: number of deaths due to stroke, and dALys lost per 100,000 inhabitants in 1995 
and 2015 (age- and sex-standardised to the world standard population, GBd 2015)
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The GBD study shows large inequalities 
in the rate of strokes and mortality due to 
stroke across Europe, with higher rates and 
poorer outcomes being consistently found 
in Eastern European compared to Western 
European countries� 
Across Europe the age-standardised rates 
of strokes, deaths from strokes, and people 
living with disability as a result of stroke have 
gone down�  But relative improvements have 
been larger in Western European countries 
than in Eastern European countries�
The latest Eurostat (statistical office of the 
EU) cardiovascular disease statistics add 
further evidence (data extracted October 
2016, http://ec�europa�eu/eurostat)� The 
Eurostat stroke mortality figures show that 
the highest standardised death rates for 
stroke were reported for Bulgaria, Romania, 
Serbia, Latvia, Lithuania, Croatia, Hungary, 
and Slovakia, while the lowest rates were 
reported for France, Spain, Luxembourg, 
Austria, and Belgium� Mortality rates in 
Bulgaria (highest rate) were almost seven 
times as high as those recorded for France 
(lowest rate)�
However, there are currently no Europe-
wide standardised, nationally collected 
data on stroke, leading to a significant 
level of uncertainty due to poor or missing 
data in many parts of Europe, as seen by 
the widely differing estimates derived from 
population-based registers, hospital data 
sets, or GBD� For example, for the UK there 
is a large discrepancy between the number 
of strokes estimated for 2015 in the GBD 
study (43,000) and estimates based on 
the national stroke audit (110,000)[75]� This 
illustrates that estimates of the burden of 
stroke on a country level, comparisons 
between countries and healthcare systems, 
and future projections all have significant 
caveats at present�
@Katemangostar - Freepik�com
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1.7 What do we predict about the future burden of stroke in Europe?  
The evidence shows that age-standardised 
incidence rates for stroke are falling� This is 
welcome, but this trend is outweighed by 
an ageing population� Improved survival 
rates from stroke mean there will be more 
people living with stroke as a long-term 
condition�
Models estimating future stroke burden 
usually combine national demographic 
projections with estimated incidence and 
survival rates, sometimes covering a best 
case and worst case scenario� Based on 
these methods, a 36% increase in the 
number of stroke events was predicted for 
the European Union combined with Iceland, 
Norway, and Switzerland between 2000 
(1�1 million) and 2025 (1�5 million)[76]� Only a 
few studies have calculated future stroke 
burden on a country-level, but they are all 
predicting a significant increase (Table 5)�
table 5: european studies estimating the future burden of stroke
Country
Projection 
period
Estimate
netherlands[62] 2000 - 2020 Incidence: +17% 
Prevalence: +16%
Potential Years of Life Lost: +30%
Finland[77] 2000 - 2030 Number of strokes nationally assuming
•  Stable incidence rates: +75%
•  Incidence rates continue to decline: +5% 
Germany / 
Hesse[78]
2005-2050 Number of strokes regionally assuming stable 
incidence rate: +68%
Ireland[79] 2007 - 2021 Number of strokes nationally assuming stable 
incidence rate: +58%
sweden[23] 2001/2 - 2050 Number of stroke cases nationally assuming
•  Stable incidence rates: +59%
•  Rates decreasing 2% every 5 years: +33%
•  Rates increasing 2% every 5 years: +91%
Italy[80] 1991-2016 Number of strokes nationally assuming stable 
incidence rate: +22%
uK[81] 1983 - 2023 Number of strokes nationally assuming stable 
incidence rate: +30%
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For this report, we have calculated 
epidemiological projections for all EU 
countries for 2025 and 2035 using the most 
recent age and sex-specific GBD incidence, 
prevalence, death, and DALY-rates� These 
rates were applied to the demographic 
projections for each country (broken down 
by age and sex) obtained from Eurostat  to 
obtain projected absolute numbers� Again, 
we want to emphasise that a significant level 
of uncertainty is attached to all country-level 
estimates� However, as percentage change 
over time in our model depends purely 
on changes in the demographic make-up, 
those percentage changes should be more 
reliable than absolute figures�
Using GBD incidence rates, between 2015 
and 2035, there will be a 34% increase in 
total number of stroke events in the EU from 
613,148 in 2015 to 819,771 in 2035� 
This is consistent with the expectation that 
the ageing of the population will outweigh 
the drop in age-standardised incidence rates 
(figure 3)� The largest percentage increase 
will be seen in Luxembourg (78%) and 
largest absolute increase in Poland (26,807) 
(Figure 3)� Our projections for the percentage 
change in stroke events and DALYs lost 
2015-2035 can be found for each country 
in the separate report named “Overview 
of stroke burden and care in each EU and 
SAFE member country, SAFE, 2017”�
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Figure 3: estimated number of strokes in 2015 and 2035 in eu countries 
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The number of stroke survivors in the EU will 
rise from 3,718,785 in 2015 to 4,631,050 in 
2035, an increase of almost one million or 
25%� 
The largest increase will be in Luxembourg 
(72%) and the largest absolute number 
increase  in the UK (193,861)�
there will be a 45% increase in the number 
of stroke deaths from 532,321 in 2015 to 
770,038 in 2035.
This ranges from a 10% increase in Lithuania to 
101% increase in Malta, with Germany having 
the largest absolute increase of 29,243�
overall there will be a 32% increase in dALys 
lost from 2015 to 2035 (609,721 to 861,878).
The largest percentage increase is expected 
in Malta (63%) with almost no change in 
Lithuania (1%)� The UK will have the largest 
absolute increase of DALYs from 609,721 in 
2015 to 861,878 in 2035�
3,718,785
4,631,050
45% 
more deaths
32% 
more 
DALYs lost
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1.8 The financial and social burden of stroke
In the EU, the total cost of stroke in 2015 
was calculated as €45 billion[82]� 44% of 
this amount, i�e� €20 billion, was caused by 
direct health care costs� 72% of direct health 
care costs were for in-hospital care and 7% 
for drugs� Figure 4 shows the direct health 
care costs of stroke per capita in 2015� For 
comparison, the crude incidence rate of 
stroke in 2015 (GBD 2015) is included in 
figure 4 and demonstrates that there is no 
association between national per-capita 
spending and the national rate of new 
strokes�
Direct health care cost per capita varied 
widely across the EU, from €132 in Finland to 
€7 in Bulgaria, or by a factor of 19� The overall 
health expenditure also varies between 
European countries[83] and the proportions 
of overall health expenditure spent on 
stroke varied less between countries than 
the stroke-specific expenditure per capita: 
Finland and Hungary spent 4% of their total 
healthcare expenditure on stroke, while 
Denmark spent less than 1%� The amount of 
money spent on stroke therefore depends 
on the significantly different overall national 
healthcare budgets, but also on varying 
allocations within that budget� 
Most studies measuring the cost of stroke 
only look at direct health care costs�  This 
hugely underestimates the total cost of 
stroke because it does not take into account 
non-health care costs including informal 
care (the opportunity cost of unpaid care 
provided by family or friends), or productivity 
lost due to death or disability� 
Informal care costs alone were estimated 
at €15.9 billion or 35% of the total cost of 
stroke in the eu in 2015. Productivity losses 
were estimated to be €5�4 billion or 12% for 
losses due to death and €4�0 billion or 9%, 
for losses due to morbidity� 
The economic burden of stroke is borne by 
society as a whole via tax payments and 
insurance contributions, but significantly 
also by the individual stroke survivors and 
their families and friends� Figure 4 shows 
non-health care costs of stroke for EU 
countries in 2015, again in comparison with 
GBD estimates of stroke prevalence, i�e� the 
number of stroke survivors, in 2015�
As the number of strokes and the number 
of stroke survivors is expected to increase 
over the coming decades, the economic 
impact of stroke will need more attention 
with regards to effective health care 
planning and resource allocation[84] as well 
as the financial burden borne by stroke 
survivors and their family and friends�
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Figure 4: Health care and non-health care costs of stroke per capita in 2015 in euro and 
crude incidence and prevalence of stroke per 10,000 inhabitants in 2015 (GBd 2015)
As well as the economic impact of stroke, stroke survivors commonly experience a wide range 
of negative physical and mental consequences� These are often long-lasting and can have 
a large impact on the lives of patients and their families� Impaired mobility, vision, speech, 
depression, and cognitive impairments such as memory problems, personality changes, and 
fatigue are typical[3]� 
By their nature, the impacts of these impairments are complex and hard to quantify� There 
should be more research into patient-reported experience and outcome measures, and 
quality of life studies� SAFE believes that patients, carers, and patient organisations/SSOs 
should be actively involved in these studies as participants and co-researchers� 
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“My GP was the best, she 
was fantastic. [But] when it 
came to the real crunch of it, 
that big part down the line, I 
spoke to her and she hadn’t 
got a clue[about longer term 
support]. It’s like thinking, 
how do you educate the 
medical profession to better 
understand about the whole 
person’s needs? Because it all 
focuses around ‘treat them in 
the hospital, rehabilitation, get 
them out into the community, 
six weeks’ support … and then 
you’re on your own.’ ” 
(Male stroke survivor, 
UK)
“There are a lot of things 
that I cannot do that I 
did before. I was fond of 
skiing – I cannot do that. 
I cannot ride a bicycle 
because I have no 
balance, and things like 
that. You miss it, but after 
some time you get used 
to it. It’s a new life; you 
have to adjust to what 
you can do.” 
(Male stroke survivor, 
Norway)
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1.9 Recommendations - The Burden of Stroke 
There is a lack of unified data about stroke and stroke outcomes� Europe-wide comparisons 
of stroke and stroke care are vital to help each country prevent stroke and provide better 
care and support for everyone affected by stroke� To make accurate comparisons between 
different countries, populations and health systems we need agreed and coordinated 
Europe-wide data collection� Therefore, European policy-makers, in particular the European 
Commission and the Joint Research Centre, should support and promote the use of a robust 
Europe-wide stroke register to assess quality of care along the whole stroke pathway�
The number of people having a stroke and the number of people living with the long-term 
effects of stroke will rise in the coming decades�  Effective health care planning and adequate 
resource allocation across Europe is needed to deal with this, taking into account that the 
financial burden of stroke is to a large extent borne by stroke survivors themselves and their 
families�
There are limitations to the current research evidence from the perspective of European 
stroke survivors (for example, it is largely based on small studies from mostly Western 
European countries)� This research should be conducted more widely throughout Europe, 
and consolidated findings should be used to influence patient care� SAFE believes that these 
studies should actively involve stroke survivors and patient organisations�
despite public education campaigns, public knowledge about the risk factors for stroke is 
too low.  Perhaps as a result, high blood pressure and atrial fibrillation (AF, an abnormal 
heart rhythm with rapid and irregular beating) are often not treated or not appropriately 
treated. this section outlines what is being done across europe to tackle two important, 
modifiable risk factors for stroke.
stroke is preventable.  
Ten modifiable risk factors account for 
around 90% of all strokes[85]�  The most 
important are high blood pressure, high 
cholesterol, smoking, obesity/diet, atrial 
fibrillation, and diabetes� 
The proportion of the population estimated 
to have one or more stroke risk factors 
is high and varies significantly between 
countries (Figure 5[86]) 
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“I suffered a cerebral venous thrombosis in 2011 (I was 34 years 
old)…I was a journalist, editor of a weekly magazine…I did not 
have the time nor patience to practise sport…In addition to 
stress and sedentary lifestyle, also the use of oral contraceptives 
contributed – in the opinion of doctors - to my stroke” 
(Female stroke survivor in 2011, Portugal)
Figure 5: Percentage of the population in european and sAFe member countries affected 
by some of the major vascular risk factors, ranked by the prevalence of hypertension
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2.1 Campaigns to encourage healthy lifestyles and risk factor awareness 
(indicator 1)
Even though stroke is preventable, 
knowledge of the risk factors is poor
(Bulgaria[87], Croatia[88], Denmark[89], 
Estonia[90], Germany[91], Greece[92], Ireland[93], 
Sweden[94])�
High blood pressure (hypertension) is 
the most commonly known risk factor� In 
a Greek study 66% named hypertension 
as a risk factor for stroke, but only 44% 
recognised smoking and 34% obesity as 
a risk factor[92]� In a Danish study, only few 
subjects recognised smoking or diabetes 
mellitus as major risk factors[89]� Importantly, 
only a small proportion of patients with risk 
factors consider themselves as being at 
high risk[88, 92]� 
Most countries have undertaken regional 
or national educational campaigns aimed 
at raising awareness of stroke risk factors 
and healthy lifestyles using a multi-media 
approach� These campaigns are often 
combined with campaigns to increase 
public knowledge of stroke symptoms and 
the appropriate response� 
Events are held across most of Europe 
in connection with World Stroke Day 
(www�worldstrokecampaign�org) including 
multi-media campaigns; public lectures; 
and events/information stalls in public 
spaces like hospitals, shopping malls, or 
libraries (e�g� free pop-up blood pressure 
measurement points)� These events are 
often organised by the regional or national 
SSOs� 
Other examples are the Czech HOBIT 
Programme which aims to increase school 
children’s knowledge of stroke risk factors 
and symptoms (www�projekthobit�cz, 
Chapter 3�1), the Belgian annual “Heart 
Rhythm Week” with free screening in 
hospitals and activities to raise awareness 
around atrial fibrillation[95], or the Finnish 
blood pressure campaign�
© MisitaPR
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Although many campaigns have been 
undertaken, very few have been evaluated 
systematically� The few campaigns that have 
been assessed showed varied success with 
regards to improved risk factor knowledge 
(Czech Republic: no effect[96], Germany: 
improved knowledge[91]) or, even more 
importantly, behaviour change[97]�
Example from Finland: The Finnish Brain Association ran a 
national blood pressure campaign, which was awarded a 
World Stroke Organisation prize in WSO prize winner 2016. 
The campaign used radio, social media, a website and digi-
screens in trams and metros. The radio campaign reached 
2.85 million Finns. 121 pop-up measurement points were 
set up and, 6,002 people’s blood pressure was measured. 
© Can Stock Photo / dolgachov
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2.2 Hypertension (indicator 2)
Hypertension is the most important risk 
factor for stroke[85]� Despite this, national 
data of blood pressure levels or blood 
pressure control is not systematically 
collected in most European countries�  The 
accuracy of existing figures is dependent on 
access to diagnostic testing and monitoring 
which varies from country to country� 
According to WHO estimates (Figure 5), 
high blood pressure affects 20% of the 
population in Israel rising up to 39% in 
Estonia� As observed in previous studies[98], 
there is generally a higher prevalence in 
Eastern European countries�
Eurostat (Cardiovascular disease statistics, 
data extracted October 2016, provided by 
European Health Interview Survey (EHIS), 
2006-10) found a similar East-West gradient� 
The highest percentage of self-reported 
hypertension (adults aged ≥15 years) was 
recorded in Hungary (32%), Bulgaria (30%), 
Latvia (29%), Germany (29%), and Lithuania 
(28%), whereas the lowest shares were 
recorded in Norway (13%), France (14%), 
Sweden (16%), the United Kingdom (16%), 
and the Benelux countries (all below 17%)� 
A significant age-gradient was observed for 
hypertension with 52% of those aged over 
75 years being affected, ranging from 36% 
in Belgium to 73% in Bulgaria�  Hypertension 
is significantly more common in stroke 
patients than in the general population 
(Appendix 1, Table 1)� There are again 
significant variations between countries and 
studies� Prevalence rates for hypertension 
ranged from 54% in Spanish and Italian 
studies to 87% in a Croatian study� 
Stroke guidelines issued by the European 
Stroke Organisation in 2008 include primary 
prevention measures, such as regular 
checks of blood pressure, blood glucose, 
and cholesterol, as well as advocating a 
healthy lifestyle with regards to smoking, 
alcohol, physical activity, and diet� 
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the vast majority of european countries have developed national guidelines for the 
primary and secondary prevention of stroke covering all or most of those risk factors. 
Some countries have developed secondary 
prevention, but no primary prevention 
guidelines (e�g� Czech Republic[9]), or have 
national guidelines that cover only some 
risk factors, while local guidelines cover 
other aspects (e�g� Greece and Malta: no 
national hypertension guideline[9])� There 
are very few countries that have no national 
or local guideline covering hypertension, 
e�g� Latvia[9]�
Despite the wide availability of guidelines, 
there is significant under-treatment. 
Figure 6 shows the percentage of 
the population reporting the use of 
antihypertensives in 15 European countries 
in 2008 according to Eurostat data 
(http://appsso�eurostat�ec�europa�eu) 
together with the estimated percentage 
of the population affected by high blood 
pressure[86]� Clearly, there is a considerable 
issue of under-treatment� In several other 
European studies, low treatment rates of 
hypertension have been observed, but with 
some improvements since 2000 (Table 6)�
Figure 6: Population affected by hypertension (WHO data) and self-reported use of 
antihypertensives (Eurostat 2008 data, ranked by the relative gap between hypertension 
and the use of antihypertensives 
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table 6: Percentage of hypertensive patients taking antihypertensives (primary prevention)
Country % - year Further details; other studies
General 
population
Portugal 39% - 2003 national sample, control rate 11%[99]
spain 59% - 2008-10 national sample[100]
Italy 64% - 2013-4 national sample[101]
Germany 55% - 1998 
72% - 2008/11 
multi-centre[102]; significant regional 
differences[103]
Pre-stroke estonia 58% - 2001-3 Tartu stroke register[14]
Poland 78% - 1995/9 
91% - 2010/13
Warsaw stroke register[104]
uK 55% - 2007-10 South London Stroke Register[105];
significant increase in patients prior to and 
in the year after stroke (UK primary care 
database 1999-2008)[106]
Even more important than treatment rates are control rates�  What proportion of people 
are getting treatment that is enough to lower blood pressure to recommended levels? Low 
control rates have been reported from many European countries� Two large international 
studies using primary care data, the EUROASPIRE primary care surveys[107] and the EURIKA 
study[108] consistently showed low control rates in hypertensive patients between 48% in 
Greece and 28% in Romania (Figure 7)� Similarly, several national or local studies reported 
low control rates in treated patients between 33% (Greece) and 72% (Germany) (Table 7)�
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Figure 7: Proportion of hypertensive patients with controlled blood pressure 
(<140/90mmHg, EURIKA: proportion of all hypertensive patients (treatment rates >90%), 
EURASPIRE: proportion of treated patients)
 
table 7: Proportion of hypertensive patients with controlled blood pressure (Control rate)
Country Control rate
Austria [109] 41% of treated, and adherent patients 
spain[100] 43%  of treated patients, 25% of hypertensive patients 2008/10 
(16% in 2000/1)
Italy[101] 58% of treated patients in 2013/14, 33% in 2000 to 2011
Italy[110] 47% of treated patients
Greece[111] 33% of treated patients (51% of hypertensive patients were 
treated)
Germany[112] 72% of treated patients in 2008/11, 42% in 1998
Portugal[113] 37% of hypertensive patients in 2008/9
Iceland[114] 27% of hypertensive patients in Icelandic GP database
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Low control rates for hypertension are also found among people who have had a stroke 
(i�e� secondary prevention)�  Figure 8 presents data from the stroke-specific module of the 
EUROASPIRE study (2006-8 data[115]), showing control rates of 32% or less in those with 
known hypertension in four European countries� An Irish stroke population study (6 months 
after ischaemic stroke), modelled on the EUROASPIRE protocol, found uncontrolled blood 
pressure in 63% of patients[116]�
Figure 8: the percentage of hypertensive stroke patients treated with antihypertensives 
(treatment rate) and of those achieving adequate hypertension control (control rate)
Measuring how many people get treatment 
does not accurately reflect how many 
people’s high blood pressure is being 
controlled� Blood pressure control is 
a relevant measure that needs to be 
encouraged in future studies�
It is clear that existing guidelines are not 
being implemented well in every day clinical 
practice; there are poor treatment rates for 
hypertension across Europe and even worse 
hypertension control rates, although several 
studies do report some improvement over 
the last decade�  
Across europe primary and secondary prevention strategies  
are not working well enough to control hypertension,  
the biggest risk factor for stroke.  
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2.3 Atrial fibrillation (indicator 3)
Atrial fibrillation (AF, an abnormal heart 
rhythm with rapid and irregular beating) is 
estimated to increase the risk of stroke 3 
to 5-fold and to be associated with around 
a quarter of all ischaemic strokes[117-119]� 
Additionally, AF is associated with more 
severe strokes leading to higher mortality 
and disability[120]�
2% of patients attending the emergency 
room with AF had a stroke within 1 year in 
Western Europe and 4% in Eastern Europe, 
according to a large international cohort 
study[121]� The 2016 European Society 
of Cardiology (ESC) Guidelines for AF 
Management[122] recommend that anyone 
over 65 years or at high risk of stroke is 
screened for atrial fibrillation�
AF is often asymptomatic and screening 
is not routinely undertaken in Europe� 
Accurate information on its prevalence 
in the general population is therefore not 
widely available� Some European countries 
have undertaken screening studies to 
estimate the proportion of the population 
affected (Appendix 1, Table 2)� They reported 
rates in the general population ranging 
from 1�3% (UK, Italy) to 3�9% (Greece), with 
rates being highly dependent on age� Less 
data is available from Central and Eastern 
European countries�
Screening studies also found that between 
10% and 66% of people with AF were 
previously unknown cases (Belgium[95], 
Portugal[123], UK[124], Spain[125])� This implies a 
significant under-diagnosis in Europe�  A UK 
trial showed that opportunistic screening 
with simple pulse palpation resulted in 
significantly improved detection rates[126]�  A 
major screening study has been launched 
in Sweden to detect AF and to see whether 
screening reduces stroke incidence and is 
cost effective[127]� 
AF is significantly more common in people 
who have had a stroke than in the general 
population� Reported prevalence rates 
are as high as 31-38% in a Greek study 
(Appendix 1, Table 1)� Variations are also high 
within countries and studies with similar 
methodologies (e�g� Italy[128], Appendix 1, 
Table 1)�  
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AF is often only diagnosed after someone 
has had a stroke: studies from Ireland[129], 
Iceland[16], Croatia[130] and Norway[131]  
reported that between a quarter to over 
half of AF diagnoses known after stroke 
were unknown before� A recent meta-
analysis also reported that 24% of stroke 
patients are newly diagnosed with AF 
after their stroke[132]� These reports again 
suggest a significant under-diagnosis of AF 
in the general population� Better detection 
rates of AF could lead to improved primary 
prevention�
Due to Europe’s ageing population and AF’s 
strong association with age (0�7% in those 
aged 55-59 vs� 17�8% in those aged ≥85 
years,[133]), the prevalence of AF is expected 
to rise� Using data from the community-
based Rotterdam Study and population 
projections from Eurostat, it was estimated 
that the number of adults over 55 with AF 
will more than double between 2010 and 
2060 from 8.8 million to 17.9 million[117]� An 
Icelandic study projected the prevalence 
of AF to rise from 1�9% in 2008 to 3�5% in 
2050[134]� 
In the UK, the number of AF related 
ischaemic strokes has trebled in the last 
25 years in adults over 80 years and is 
predicted to treble again by 2050, with 
AF-related embolic events costing the UK 
around £374 million per year[135]� 
AF is therefore an important part of 
European[136, 137] and most national stroke 
guidelines, both for primary and secondary 
prevention� However, some European 
countries have not developed national 
guidelines covering AF treatment in relation 
to stroke primary prevention (Czech 
Republic, Greece, Latvia, Estonia,[9])
The ESC Guideline recommends treating 
AF patients following a structured risk 
assessment with oral anticoagulants for 
those with high risk scores[136]� Several 
recent, international European studies have 
assessed treatments rates of AF patients 
with oral anticoagulants (Table 8)�  
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table 8: International oral anticoagulants treatment studies
Study Countries included and treatment rates*
PreFer-AF study[138] 2012: France: 90%, Germany, Austria, Switzerland: 87%, Italy: 
72%, Spain: 88%, UK: 78%, CHA2DS2-VASc score: score≥2: 
86%, score=0: 63%
eorP-AF study[139, 140] 2012/13: Western Europe (Belgium, Denmark, Netherlands, 
Norway): 72%, Eastern Europe (Poland, Romania): 74�7%, 
Southern Europe (Greece, Italy): 76%, CHA2DS2-VASc>=2: East 
(93%, South: 95%, West 81%)
BALKAn-AF survey[141] 2014/15: Bulgaria: 73%, Croatia: 84%, Romania: 76%, Serbia: 
79%� High treatment rates but poorly related to CHA2DS2 
-VASc score: score≥2 74%, score=0 57%
euro Heart survey[142] 2003/4: 67% of eligible patients compared to 40-50% of low 
risk patients (according to CHA2DS2-score)
GArFIeLd-AF 
registry[143]
Global register, including Poland, Finland, Norway, Sweden, 
UK, Denmark, France, Germany, Netherlands, Belgium, Austria, 
Italy, Spain, Czech Republic, Hungary: overuse of OAC in low 
risk, underuse in high risk patients
re-Ly Atrial Fibrillation 
registry[144]
International study, AF patients attending ER: CHA2DS2-Vasc 
score≥2: 63% in Western Europe, <40% in Eastern Europe, 
proportion of INR values between 2�0 and 3�0: 67% in Western 
Europe, 59% in Eastern Europe
Gloria-AF[145] Global register, including Austria, Belgium, Bulgaria, Croatia, 
Czech Republic, Denmark, Estonia, France, Germany, Greece, 
Ireland, Italy, Latvia, Netherlands, Norway, Poland, Portugal, 
Romania, Slovenia, Spain, Sweden, Switzerland, UK:
High treatment rates (90%), but over-use in low risk patients
*The CHA2DS2-VASc-score is a validated risk stratification scoring system, including 
congestive heart failure, hypertension, age, diabetes mellitus, stroke/TIA/ thromboembolism, 
vascular disease, and sex�
Generally, these studies found relatively high oral anticoagulant treatment rates, but treatment 
was often not in accordance with the guidelines and patients’ specific risk profiles� Under-
use of oral anticoagulants in elderly patients[146] or those with high risk scores and over-use in 
those with low risk scores was observed� 
The Burden of Stroke in Europe
55
Also, the majority of these studies recruited patients registered with cardiologists (PREFER-
AF, EORP-AF, BALKAN-AF, Euro Heart Survey, Gloria-AF)� So the generally high treatment 
rates might not be representative for patients in primary care� 
Several smaller studies, particularly those using primary care data or data from screening 
studies, discovered much lower rates (Table 9)� These figures might be more representative 
of real-life AF anticoagulant treatment� Again, a mismatch between treatment and patients’ 
risk scores was observed, showing poor adherence to guidelines�
table 9: oral anticoagulant treatment rates in national/regional studies 
Country Oral anticoagulant treatment rates
denmark 66%, with 76% treated according to guideline (2011 primary care data)[147];
67% in 2015 for newly diagnosed AF patients (was 40-50% in 2010)[148]
Germany 71% treated according to guideline (2004-6 data)[149]
Greece 41% of eligible AF patients on oral anticoagulants, 34% on antiplatelets, 25% 
no therapy (screening study,  rural Greece)[150];
>55% of intermediate risk and 67% of high risk AF patient not on oral 
anticoagulants[151] 
Italy 84% at time of diagnosis (2% had low CHA2DS2-VASc score), but only 30% 2 
years after diagnosis (2009-11 data, primary care)[152])
Poland 41% of eligible AF patients on oral anticoagulants (2006/10 data, cardiology/ 
internal medicine/ neurology wards)[153]
spain 24% of AF pat >60 years with CHA2DS2-VASc≥2 not on oral anticoagulants, 
female gender, older age, cognitive impairment related to lower rates[154]
sweden 53% of eligible AF patients on oral anticoagulants (2005-10 data)[155] 
uK 53%, with 8% of very high risk patients no treatment, 38% of low risk patients 
on oral anticoagulants, lower treatment rates in elderly (2003 primary care 
data[156] 
Some studies have investigated oral anticoagulant treatment rates for AF in a stroke 
population (Table 10)� Before stroke, rates were found to be very low� After stroke, rates were 
slightly higher, but still low and varied significantly between studies and countries� Older 
age was a significant predictor of lower treatment rates[157]� There is a trend towards higher 
treatment rates in more recent studies�
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table 10: Anticoagulation rates in AF patients before and after stroke (primary and 
secondary prevention)
Country Rate
Before 
stroke
Austria 16% patients diagnosed with AF prior to or at admission, 1999/2000 
stroke register data[158]
Finland 55% patients with CHA2DS2-VASc-score ≥2, 49% in 2003 rising to 
65% in 2012[159] 
Ireland 39% 2015[129]
Poland 40% in 2010/3, compared to 6% in 1995/9[104] 
sweden 16% known AF, prior to ischaemic stroke, 2005-10 stroke register 
data[160] 
uK 23%
25%           
46%
in 2011, compared to 12% in 1995[105] 
poor correlation with CHA2DS2-Vasc score (1999-2008 
primary care data[106] 
those in AF on admission[161]
After 
stroke
Austria 33% at discharge in 1999/2000[158]
France 91% 2004-6, local stroke register data[162]
Germany 55% 2008/9 national audit data[163]
Ireland 84% 6 months after ischaemic stroke, 2011 data[116] 
Italy 74% 2004-6, local stroke register data[162] 
Lithuania 37% 2004-6, local stroke register data[162] 
Poland 21%
22%
2008/9 national audit data[163]
2004-6, local stroke register data[162]
spain 59%
23%
pat with embolic infarction in 2009[164] 
2004-6, local stroke register data[162]
sweden 63% / 
9%
35%                   
37%
in 18-64 / in>85a, 2005 data[157] 
within the first 3 months after stroke, 2005-10, national stroke 
register data[160]
2008/9 national audit data[163]
uK 34%
40%
2008/9 national audit data[163]
2007-2012 local stroke register data; was 18% in 2004-6[162] 
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The spread of novel oral anticoagulants 
(NOAC) (now known as non-vitamin K 
antagonist oral anti-coagulation) will 
overcome some obstacles to the use of 
traditional oral anticoagulants (the need 
for frequent monitoring, for example), and 
might improve treatment rates� However, 
their uptake has been reported to be 
slow[138]: use of NOAC in Italy: <1%, UK: 4%, 
France: 6%, Spain: 11%, Germany: 12%� The 
National Health Service in England reported 
that most areas had a NOAC uptake below 
20% of oral anticoagulants with wide 
variations (4% to 69%)[165]� In Poland, 19% 
of anticoagulated AF patients discharged 
from cardiology were using NOAC[166]� More 
encouragingly, a German study of four 
tertiary stroke centres reported that half of 
ischaemic stroke patients discharged with 
anticoagulation were prescribed NOAC[167] 
and recent European data from GLORIA-AF 
show that 52�3% of all oral anticoagulant 
prescriptions for newly diagnosed AF 
patients were NOACs[145]� A recent Danish 
study found 73% of all prescribed oral 
anticoagulants being NOAC in 2015[148]� 
In conclusion, the prevalence of AF is expected to rise significantly over the next few decades 
due to an ageing population and there is evidence of severe under-diagnosis� Anticoagulation 
rates reported from large surveys using specialist cardiology set-ups are encouraging but 
studies using primary care data show much lower treatment rates, particularly in the older 
age group[156, 157]� Retrospective analyses of treatment rates in AF patients prior to stroke are 
lower still (16-39%)�  Adherence to available treatment guidelines and the recommended use 
of risk stratification is still insufficient[168]� 
Treatment rates after stroke were higher, but still showed 
much room for improvement�
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2.4 Transient ischaemic attack (TIA) (indicator 8)
TIA is known as a mini-stroke and defined 
as a focal neurological deficit lasting less 
than 24 hours caused by a focal, temporary 
cerebral ischaemia� Its main significance 
lies in the increased risk of subsequent 
stroke� A recent large international study 
found a 5% risk of stroke within one 
year of TIA[169]� An Italian study found a 
6% and 11% risk of stroke within the first 
7 and 90 days of TIA respectively[170]� 
Other studies also reported a particularly 
high risk in the first few days after TIA[171, 172]� 
Studies calculating the 90-day stroke risk 
for patients having been urgently assessed 
after TIA found much lower risks of 
subsequent stroke[173, 174]� 
Urgent assessment and starting of stroke 
prevention treatment is, therefore, essential 
to lower the very substantial risk of 
subsequent stroke�
There is little epidemiological data regarding 
the number of TIA events per population� 
Incidence of TIA in Europe was reported as 
0�5-2�4 and 0�1-1�1 in men and women aged 
55-64, rising to 3�0-7�2 and 2�2-8�1 in those 
aged 75-84[175]� Age-adjusted incidence 
rate was reported as 73 per 100,000 in 
Sweden[176], 25 in Italy (Udine)[170], and 29 
in Spain[21]� Crude incidence was 101 per 
100,000 in Croatia[177]� The proportion of the 
population which has experienced a TIA in 
the past was estimated at 0�5% in the UK[67], 
1�3% in Spain[64], and 1�4% in Croatia[58]�
In most European countries national stroke 
guidelines cover TIA management (Austria, 
Belgium, Bulgaria, Czech Republic, Finland, 
France, Ireland, Italy, Latvia, Luxembourg, 
Malta, Germany, Hungary, Sweden, Spain, 
and UK), while some countries use local 
guidelines (Croatia, Greece, and Slovakia)�
[9, 178]
Several European countries have to some 
extent a dedicated system for the care of 
people with TIA (immediate or same day 
evaluation of patients by a stroke specialist): 
Belgium[9], Croatia (one outpatient 
centre only[9]), Czech Republic, Denmark, 
France[179], Germany, Italy, Ireland, Israel, 
Portugal, Serbia, Slovakia, Slovenia[9] Spain, 
UK[169])�  Several countries lack specialised 
outpatient services and TIA patients are 
usually admitted for diagnostic tests (Austria, 
Estonia, Slovakia[9])� However, there is no 
information available for several European 
countries and the extent, availability, and 
population coverage of the services in the 
countries listed above is largely unclear�
example from slovakia: “There is no 
chance for patients with TIA to pass all 
recommended examinations (ultrasound 
of carotid arteries, ECG, Holter monitoring, 
echocardiography, etc.) in short time 
(sometimes it could last 3 months). That is 
why they are admitted to hospital, where 
they pass most of these examinations in a 
few days (it depends on the hospital how 
many days) and most of them are discharged 
from hospital with secondary prevention”.[9]
example from Croatia: “There is only 
one TIA Centre in Croatia providing 
best outpatient medical care within 
24 hours (diagnostics and therapy) for 
low risk TIA or mild stroke patients[…] 
It has full access to all diagnostics 
(neuroimaging, cardiology, ultrasound, 
biochemistry) with the limitation of not 
being available on weekends so far. Other 
hospitals either admit TIA patients to 
general neurological wards or discharge 
them home for further workup”.[9]
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2.5 Recommendations - Preventing stroke
A more systematic, evidence-based approach to public education across the EU is required 
to improve knowledge of the modifiable risk factors for stroke, i.e. an awareness that these 
factors significantly increase a person’s risk of stroke, but in most cases can be treated. 
Joining forces with public education efforts in relation to the other cardiovascular diseases 
could create a more powerful message and greater impact.  
Current educational campaigns should be assessed for their effectiveness. Our 
understanding needs to go beyond measuring public knowledge and awareness to look at 
the extent to which they positively influence public behaviour over time. We should build on 
what works and make sure public education is both effective and cost effective. Innovative 
campaigning methods (such as: the use of social media, apps; collaborative campaigns in 
co-operation with other medical specialties; risk factor education in schools; and risk-factor 
checks in places such as workplaces or pharmacies) should be assessed.
Across Europe we need rapid and concerted action to prevent stroke and, especially, 
improvement in the detection and treatment of high blood pressure (hypertension) and 
atrial fibrillation (an abnormal heart rhythm with rapid and irregular beating). Medical 
professionals and patients must both be involved through shared decision-making, in order 
to increase adherence to existing guidelines, compliance with prescribed medications, and 
regular blood pressure checks. 
Improvement in the diagnosis and management of AF is needed including systematic 
approaches to identifying and monitoring AF. The effectiveness and cost-effectiveness of 
AF screening policies of at-risk populations should be assessed in the respective health 
contexts of each country, as do new developments such as devices and apps for detecting 
AF, self-monitoring of INR, and new anti-coagulation therapies. A more systematic approach 
to monitoring guideline adherence (e.g. national or large regional audits), and possibly 
incentivising this adherence might improve treatment rates.
Timely assessment of suspected TIA patients in specialist clinics should be widely available.
© Can Stock Photo / obencem
© Can Stock Photo / chungking
3. 
stroKe As A 
MedICAL eMerGenCy
The Burden of Stroke in Europe
61
Lack of public knowledge about stroke 
symptoms and that stroke is an emergency 
is an important cause of delays in people 
getting emergency stroke care.  once in 
the hospital, there are large variations 
across europe in how quickly people are 
treated by stroke specialists. this section 
looks at what efforts are being made to 
avoid delays in people getting specialist 
treatment.
The quicker stroke treatment can be started 
the better – the concept “time is brain” 
encapsulates the fact that stroke should be 
treated as a medical emergency in order to 
improve outcomes and avoid deaths from 
stroke�  Minimising the time between the 
onset of a stroke and treatment involves 
many people: 
a person having a stroke (or someone with them) needs to recognise  
the symptoms and call an ambulance; 
paramedics need to screen for stroke and take the person  
directly to the best place for specialist stroke treatment;
hospitals need to have clinical pathways that minimise delay  
(immediate access to CT scanning, for example)�  
Avoidable delays have been identified at all of these levels across several European 
countries, including those with highly organised stroke services[180] (Germany[181], Greece[182], 
Italy[183], Finland[184])� These delays are an important reason for thrombolysis still being under-
performed in most of Europe[185-187]�
3.1 Public knowledge of stroke as an emergency (indicator 4)
Public knowledge of stroke symptoms and awareness that stroke is a medical emergency 
and a treatable condition is poor. Nearly one in five people (19%) were unable to identify 
any stroke symptom, according to a large survey covering Austria, France, Germany, Italy, 
the Netherlands, Poland, Russia, Spain, and the UK�  Of the 14 symptoms presented, no one 
symptom was recognised by more than half of the respondents� only 51% would call an 
ambulance when someone has a stroke[188]�
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Numerous country-level or regional 
studies from across all of Europe support 
these findings of poor stroke symptom 
knowledge (Bulgaria[189], Croatia[88], Czech 
Republic[96, 190], Denmark[89], Estonia[90], 
France[191], Germany[91], Greece[92], Ireland[192], 
Italy[193], Lithuania[194], Portugal[195], Spain[196], 
Sweden[197], UK[198])� Two studies found a 
higher level of education related to higher 
awareness[90, 197])� There was no difference 
between urban and rural populations in a 
Croatian study[88])� Men were found to have 
poorer knowledge of stroke symptoms than 
women[89]�
Poor public awareness is a common cause 
of pre-hospital delays� An Italian study 
found underestimation of symptoms to be 
responsible for 49% of late admissions to 
their stroke unit[199]� A Dutch study found 
that, for their patients, most of the pre-
hospital delay was due to patients delaying 
contacting emergency services� That study 
estimated that 24% of stroke patients 
could receive thrombolysis if delays were 
avoided, compared to 7% actually receiving 
treatment[187]�
The European Stroke Organisation (ESO) 
guidelines recommend awareness raising 
programs and most countries have 
undertaken public campaigns to improve 
the public knowledge of stroke symptoms 
and the appropriate response�
One of the best known national campaigns 
is the award-winning Act FAST public health 
campaign launched by the Department 
of Health in the UK in 2009, including 
mass media advertisements aimed at the 
general population as well as primary care 
physicians� 
This campaign subsequently served as 
a template for similar campaigns in other 
European countries (Austria, Belgium, 
Ireland, Macedonia, Malta, Serbia, Slovenia, 
and Spain)� Many European countries have 
introduced awareness-raising activities 
around a national Stroke Awareness 
Day, often linked to World Stroke Day 
(http://www�worldstrokecampaign�org)�
example from Czech republic: HoBIt Programme:
  
“We have initiated and conducted the HOBIT program (acronym for HOdina 
BIologie pro živoT) to increase the response to stroke and heart attack symptoms 
in school children. HOBIT 1 started in 2009 and finished in July 2015 and confirmed 
excellent feasibility and sufficient efficacy of the innovative web-based multimedia 
education program for children. We now propose a population-based intervention 
(HOBIT 2), which will educate[…] also their adult relatives. The intervention tool 
will be the existing e-learning programme customised for adults. Efficacy will be 
tested by randomizing adult into target group (education + testing) and control 
group (testing). HOBIT 2 will result in a scientifically proven educational platform 
and communication strategy that can be applicable nation-wide”.[9]
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There is little research that measures the 
impact of these campaigns� Some studies 
use a reduction of pre-hospital delays 
as a proxy for the campaign’s impact� 
Evaluating the UK Act FAST campaign, a 
marked improvement in early presentation 
was seen, coinciding with the start of the 
campaign, as well as increased awareness 
of stroke symptoms[200, 201]�  
The Irish FAST campaign showed an 
initial impact on emergency department 
attendance of stroke patients, but these 
effects were not sustained in the long 
term[202]� While some found improvements 
in stroke symptom awareness following 
their campaign[91, 203, 204], others had negative 
results[96]� 
Overall, evaluation of public awareness 
programs tends to be poor and often 
doesn’t include their impact on people’s 
behaviour[205]� However, literature reviews 
on the effectiveness of stroke educational 
campaigns, including some European 
studies, generally found the potential 
to improve knowledge and change 
behaviour[205, 206]� There is therefore a need 
to systematically assess the public health 
campaigns undertaken across Europe, in 
order to prove their respective effectiveness 
and improve their impact accordingly� 
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3.2 Professional education concerning stroke as an emergency (indicators 4 and 5)
Healthcare professionals who have not 
had specific stroke training (ambulance 
and emergency staff, as well as general 
hospital staff and primary care physicians) 
can contribute to delays and therefore 
the current ESO guidelines recommend 
educational programmes for professionals� 
There is some evidence from most 
European countries that professionals are 
being educated to some extent with regards 
to stroke as a medical emergency� However, 
evidence is mainly anecdotal, relating 
to individual events, or national stroke 
guideline recommendations are being used 
as evidence� 
Few studies into the impact of such training 
programmes exist� A German study found 
reduced in-hospital delays and increased 
thrombolysis rate following an educational 
program for emergency staff[207]� 
A Finnish trial of a new emergency medical 
services training programme reported a 
reduction in the time ambulance crews 
spend assessing and treating patients 
before transporting them to hospital after 
ambulance crew training[208]� Other studies 
describe a lack of emergency staff training 
(Italy: low number of emergency staff 
activating the stroke code[193], Lithuania: 
current training inadequate[194], France: 
suboptimal professional practices and 
coordination as a barrier to effective stroke 
care pathways[191])� 
there is no clear picture across europe 
about the extent, intensity or impact of 
training that is available or systematically 
provided for non-stroke specialist medical 
staff.
“Both my brain stroke and 
my heart attack were only 
diagnosed two days later. 
I did not receive the right 
treatment in two different 
hospitals, in two different 
countries [Luxembourg and 
the Netherlands]” 
(Female stroke 
survivor)
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3.3 Emergency care pathways 
Stroke specific training for ambulance, emergency services, and other involved medical staff 
is often part of a wider effort of developing and implementing new, more efficient emergency 
care pathways on a national or regional level� Examples of stroke care pathways introduced 
in Europe and their impact (if published) are listed in table 11�
table 11: examples of european stroke care pathways
Country Stroke care pathway
Austria Tyrolian stroke pathway, introduced in 2009, covering pathway from 
symptom onset to rehabilitation, led to less in-hospital delay (median 
nationwide door-to-needle time decreased from 49 min in 2010 to 44 min 
in 2013) and increased thrombolysis rate (from 12�9% in 2010 to 16�8% in 
2013[209])
Finland “Helsinki Model” including ambulance pre-notification of stroke team, led to 
less in-hospital delay[210]
Re-organisation of in-hospital treatment pathway with shifting stroke care 
from neurologists/internist to emergency doctors, led to less in-hospital 
delay[211]
France Re-organisation of regional stroke care pathway (North of France region) 
centralised emergency service directs patients to closest SU, direct 
admission to radiology department, led to increased thrombolysis rate[212]
Hungary Lysis Alarm Program with ambulance pre-notification, led to less in-hospital 
delay and increased thrombolysis rate[213]
Italy Stroke Code system: screening by ambulance and pre-notification of 
hospital, impact: increased thrombolysis rate[214], still only 20% of stroke pat 
arrive with code[193]
Portugal Via verde do AVC, describes pre- and in-hospital pathways, implemented in 
2005, no improvement in stroke mortality rates[215], but higher thrombolysis 
rates with activated stroke code[216]
spain Stroke Code system, higher thrombolysis rate in Barcelona hospital[217-219]
uK Stroke screening by ambulance using validated tools such as FAST and pre-
notification and transport to hospital with acute specialist stroke services[220]
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Ambulance stroke screening and pre-
notification of the assigned hospital are 
a central part of most of the pathways 
listed above� They were found to improve 
thrombolysis rates, especially when 
combined with educational campaigns 
to optimise awareness and behaviour of 
patients and bystanders[214]�
The key measure to assess delays in 
hospital is how long it takes for someone 
to get treatment after arriving – the door-
to-needle time (DNT)�  This measure can 
be used to assess how efficient in-hospital 
emergency pathways and protocols for 
stroke are�
Large inequalities in DNTs were found 
between countries, but particularly 
also between different centres within 
the same country� In Slovenian centres 
60% of thrombolysed patients achieved 
DNTs under 60 min, while only 19% did in 
Slovakian centres[222]� 
Data from Croatia, the Czech Republic, 
Estonia, Hungary, Lithuania, Poland, 
Slovakia, Slovenia, and Turkey revealed 
large variations between centres[223]: in 
some centres, the chance of imaging within 
25 minutes of arrival was 93% compared to 
3% in other centres� 
Long transport times between the place of 
admission and a CT scanner was the main 
explanation given, pointing to a need to 
further re-organise stroke services� 
Data from the Stroke Knowledge Network 
Netherlands showed similar variations 
between hospitals, but also a general 
reduction in DNTs as hospital routines 
improved[224]� 
The international Safe Implementation 
of Thrombolysis in Stroke Registry with 
predominantly European data reported that 
patient volume was the strongest predictor 
of DNT times[225]�
example from Finland: The “Helsinki Model” involved several system improvements[…] at 
Helsinki University Central Hospital in Finland between 1998 and 2011, including ambulance 
pre-notification, direct triage to CT scanner transport, and administration of thrombolysis 
directly in the CT suite. In-hospital delays as analysed with annual median door-to-needle 
time were reduced from 105 minutes in 1998 to 20 minutes in 2011[210]. Those system 
changes were successfully replicated at The Royal Melbourne Hospital in Australia bringing 
DNT down to 25 minutes.[221]
example from Italy: Stroke Program in Siena Province includes direct transfer by ambulance 
or helicopter with medical assistance on board, stroke code notification, mean door-to-
needle time 48 minutes, thrombolysis with possible rescue thrombectomy, stroke unit care 
equipped with 6 semi-intensive and 10 less intensive care beds with multidisciplinary team. 
The Programme has received an award from the Joint Commission Italian Network in 2016[9]�
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3.4 Recommendations - Stroke as a medical emergency
SAFE calls for continuous and sustained awareness raising campaigns across Europe so 
that more people recognise stroke as a medical emergency� These should be included in 
national stroke strategies, financially supported by Governments and should include stroke 
survivors in their planning and implementation�
We need to know which public education campaigns across Europe have worked best, and 
why, so that success can be replicated� Systematic assessment of public health campaigns 
undertaken across Europe is required to prove their effectiveness and improve their impact� 
More collaborative working with voluntary sector organisations might improve the impact of 
campaigns� 
There should be a more systematic approach towards training healthcare professionals, using 
evidence-based methods and on-going assessment of its implementation and effectiveness� 
There is a need to improve emergency pathways in some centres in order to reduce Door-
To-Needle times�  Strategies will depend on the respective national, regional, and local health 
infrastructure�
examples from Greece[9]: Case 1 (Region of Thrace): urgent transport to a rural hospital 
(Komotini General Hospital- onset to ER time: 35 min) – emergency department:  immediate 
assessment by internist and CT scan, transport to University Hospital of Alexandroupolis 
(60Km distance): immediate assessment by the stroke team – iv. thrombolysis - transfer to 
stroke unit bed (available bed in cardiovascular intensive care unit) Case 2 (from Attikon 
University Hospital, Athens): 28-year old female with acute (onset to ER time: 125 min) right 
MCA infarction (NIHSS score 16 points) due to a proximal right M1MCA occlusion disclosed 
by TCD and CTA. The door to needle time for iv. thrombolysis was 24 min. The patient 
had substantial improvement (NIHSS 9 points). A second CTA disclosed a residual clot in 
M2MCA- transfer to the angiography suite to undergo mechanical thrombectomy. The door 
to groin time was 102 min. Complete recanalisation was achieved using a stent retriever 
(groin to recanalisation time 32 min). The patient’s neurological status further improved 
(NIHSS-score 1)
4. 
ACute stroKe CAre
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Stroke units save lives and improve outcomes, but we don’t have a Europe-wide 
applied standard of the essential elements of stroke unit care�  Despite over thirty 
years of evidence showing the difference stroke units make and despite their 
inclusion in European and national guidelines, it is estimated that only about 30% 
of stroke patients receive stroke unit care across Europe� This figure masks startling 
inequalities between countries, and in particular the East-West divide in stroke unit 
provision� This section outlines the state of hospital care for stroke across Europe, 
including access to specialised stroke units and treatments� 
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4.1 Stroke unit care (indicator 6)
Stroke units – which should provide 
coordinated, multidisciplinary care by 
personnel specialised in stroke care 
(European Stroke Organisation) – save lives 
and improve outcomes� “Stroke  patients 
who receive organised inpatient care in 
a  stroke  unit  are more likely to be alive, 
independent, and living at home one year 
after the  stroke”[226]� The 2nd Helsingborg 
Declaration stated that “all patients in 
Europe with stroke will have access to…
stroke units in the acute phase…by 2015”[227]�
Using data from recent publications as 
well as information gathered through the 
questionnaire sent to European stroke 
experts[9] we found significant differences 
between countries in the number of stroke 
units and percentage of patients treated in 
stroke units (Figure 9) ranging from <10% 
in Malta, Iceland, Romania, and Ukraine to 
>85% in Sweden and Norway� 
Lower rates of stroke unit care were generally found in Eastern Europe� However, two 
consecutive questionnaire-based surveys (CEESS Working Group, completed by stroke 
experts in the respective country) observed large variations between Central and Eastern 
European countries (included in Figure 9[229, 230])�
Overall, the number of stroke units and the percentage of stroke patients treated in stroke 
units have increased significantly since 2000� National audits in Germany, Poland, Sweden, 
and the UK showed a two-fold increase in the proportion of stroke patients treated in stroke 
units between 2004 and 2009[163]� In Spain, 39 stroke units existed in 2009 compared to 45 
in 2011[231, 232], while 17% of stroke patients were treated in stroke units in 2005 compared to 
23% in 2007[233]�  
In Finland this proportion increased by 18% between 1999 (11 stroke units) and 2007 (16 stroke 
units)[54, 234]� 2% of Irish stroke patients were cared for in a stroke unit in 2008 compared to 
54% in 2015[129]� Also in most Eastern European countries, an increase in the percentage of 
patients treated in stroke units was seen in the two consecutive studies published in 2007 
and 2015 (e�g� Czech Republic from 10% to 85%,[229, 230])� The number of stroke units in Poland 
increased from three in 1997 to 150 in 2012[235, 236]�
Across europe,  
it is estimated that only about  
30% of stroke patients  
receive stroke unit care[228].
Designed by Freepik
The Burden of Stroke in Europe
71
Figure 9: Percentage of stroke patients receiving stroke unit care
references: Norway:[9], Sweden:[53], Czech Republic:[230], UK (excluding Scotland):[237], 
Germany:[238], Poland:[230], Austria:[239], Finland:[54], Estonia:[230], Ireland:[129], Denmark:[240], 
Croatia:[230], Serbia:[230], Slovenia:[230], France:[241], Latvia:[230], Hungary:[230], Italy:[242], Spain:[233], 
Slovakia:[230], Bulgaria:[230], Romania:[230], Iceland:[9], Malta:[243]
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Many european countries report variations 
in stroke unit care between different 
regions. Urban areas are usually better 
provided for than rural areas, e�g� Greece 
with variations between major cities, rural 
areas, and islands[9]� In Spain, stroke units are 
concentrated in Madrid and Barcelona[231], 
and the ratio of stroke unit beds to 
residents was found to range from 1/74,000 
to 1/1,037,000[232]�  Of 130 Italian stroke 
units, 67% are located in Northern, 22% in 
Central, and only 11% in Southern Regions, 
which, however, contains 34% of the 
Italian population[244]� French data indicate 
that nationally 33% of stroke patients are 
treated in stroke units[241] compared to 51% 
in the Dijon Stroke Register area[162])� 73% of 
Finnish patients living within the catchment 
area of a stroke unit were treated in a 
stroke unit compared to 9% outside a 
catchment area[54]� In Austria, a stroke unit 
can usually be reached in less than 45 min, 
but some areas show travelling times of 
over 90min[245]� Therefore, within-country 
variations might be as large, or even larger 
than variations between national averages 
(if known)�
However, comparing the published proportions of stroke unit care or number of stroke units 
across countries has to be done cautiously due to several limitations� 
Firstly, due to the significant increase in stroke unit care over recent years, figures depend 
on when the data were collected� 
Secondly, some studies only looked at subsets of stroke patients, e�g� those admitted to a 
stroke unit within a certain time of hospital arrival[240] or patients spending a certain proportion 
of their hospital stay in a stroke unit[162]� 
Thirdly, some studies use only hospitalised stroke patients as their denominator (national 
audits), while others give the proportion of all stroke patients in a certain area (e�g� population-
based registers)� In this case, the proportion of stroke unit care is highly dependent on 
stroke hospitalisation rates, which again vary across Europe (estimated rates: Finland 95-
98%, Sweden 84-92%[54], Bulgaria 96%[189], Hungary 90%, Italy 87%, The Netherlands 60%, 
Scotland 62%[246])� 
Some international studies have developed 
standardised datasets, in order to be able to 
compare between countries� The European 
Registers of Stroke (EROS) Investigators 
compared the proportion of stroke patients 
in population-based studies spending more 
than half of their hospital stay on a stroke 
unit in 2004-6 and found a proportion of 
0% in Spain (Menorca), 16% in Italy (Sesto 
Fiorentino), 23% in Lithuania (Kaunas), 48% in 
Poland (Warsaw), 51% in France (Dijon), and 
65% in England (London)[162]� The European 
Implementation Score (EIS) project, using 
national audit data of hospitalised stroke 
patients, reports stroke unit treatment rates 
of 91% for Poland, 84% for Sweden, 75% for 
Scotland, and 73% in England, Wales and 
Northern Ireland in 2008[163]� Again, large 
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differences between countries/studies 
could be seen�
However, definitions of what is called a 
“stroke unit” are not always the same and 
significant differences in standards of care 
can be found� The European Stroke Initiative 
(EUSI), based on expert opinion, stratified 
“Stroke Units” into “comprehensive stroke 
centres” (CSCs, equipped with interventional 
neuroradiology, advanced neurosurgery, 
24/7 MRI) and “primary stroke centres” 
(PSCs, multidisciplinary team, stroke-trained 
nurses, 24/7 CT) and any hospital ward 
(AHW) admitting stroke patients routinely[247]� 
The European Stroke Facilities Survey, 
2005, looked at the number of hospitals 
fulfilling CSC-, PSC-, and AHW-standards� It 
found large disparities between countries, 
with only few European hospitals providing 
an optimal level of care[248]� In Estonia, 
France, Greece, and Portugal more than 
three quarters of participating hospitals 
did not provide the minimum level of care� 
Countries with a large number of small 
hospitals treating only few stroke patients, 
e�g� France and Germany, performed badly 
in this survey� 
overall, 51% of participating european hospitals caring for 
42% of stroke patients did not meet minimum standards.  
Only 5% of hospitals had facilities meeting the standards 
of comprehensive stroke centres[248]� 
Much has improved over the last decade 
in terms of the availability and standard of 
stroke unit treatment, but also the quality of 
stroke units� Poland had no CSCs in 2003, 
while by 2010 nine stroke units fulfilled the 
CSC criteria� In 2003, most “stroke units” 
failed to provide care at PSC level, but 
by 2010 all of them did[236]� In Catalonia, a 
stroke network has been operating since 
May 2006 with 6 CSCs, 8 PSCs, and 35 
Community hospitals, and those providing 
thrombolysis (6) are linked to their PSCs 
via telestroke[244]� The Czech Republic 
introduced a system with 11 comprehensive 
and 34 primary stroke centres in 2010/11[249]� 
The Central Denmark Region carried out 
a stroke care reform in 2012 involving 
centralisation of stroke care into two 
specialised centres and found increasing 
thrombolysis rates and reduced 30-day 
mortality[250]�
In two UK urban areas (London and 
Manchester), stroke services were 
centralised in 2010 into a small number of 
hyperacute stroke units for the acute phase 
and general stroke units� 
example from the Czech republic[249]:
before 2001 there was no central 
accreditation of stroke units; 2001-9: 
stroke units were accredited by scientific 
society; 2011: new system of 34 PSC/11 
CSC, accredited by Ministry of Health and 
scientific societies; 2013: 12 Quality of care 
indicators reviewed in 6-monthly audit 
(compulsory); stroke unit care of stroke 
patients increased from 10%[229] to 85%[230]; 
example from Bulgaria:
St. Marina University Hospital in Varna: 
2005 course of stroke care for nurses - 
2007 introduction of thrombolysis - 2011 
enrolled in the SITS programme - 2015 part 
of QUICK program, ESO and part of ESO-
East - 2016 registered for Angels Initiative, 
thrombolysis rate 5.8%, nationally under 
1%.[9]
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Patients admitted to hyperacute stroke units 
were shown to be significantly more likely to 
receive evidence-based interventions and 
experience better outcomes[251, 252]� Despite 
this, the 2014 UK national stroke audit (using 
a gold standard of seven stroke unit criteria) 
reported that the majority of UK stroke unit 
beds did not meet this standard[253]� So 
improvements made in some areas, in this 
case two large metropolitan areas, might not 
be representative of a country as a whole� 
The large inequalities in quantity and 
quality of stroke unit care between 
and within European countries led to 
several international (Stroke Unit Trialists’ 
Organisation, ESO) and national stroke 
organisations, e�g� Belgian Stroke 
Council, German Stroke Society, Spanish 
Neurological Society, issuing guidelines for 
the creation of stroke units using widely 
agreed standards based on evidence or 
experts consensus�
A system of official accreditation has been 
introduced on a European- and national 
level (e�g� ESO Stroke Unit and Stroke 
Centre Certification Platform launched 
in 2016)� Hospitals are encouraged to 
apply[244, 254]� Certification is now mandatory 
in some countries/areas (e�g� France) and 
financed and organised by governmental 
agencies� In other countries, it remains 
voluntary (e�g� Germany, organised by 
the German Stroke Society, the German 
Stroke Foundation and an accredited 
certification institution, and paid for by the 
hospital)�   Some European countries have 
no system of official accreditation, e�g� 
Belgium, Lithuania[244], Sweden (where the 
national audit is a driver of care quality), or 
Macedonia[178]� In many European countries 
(Latvia, Croatia, Slovakia, Lithuania, Bulgaria, 
Hungary, Poland, Greece, Czech Republic, 
Romania, Austria, France), some hospitals 
have become members of the ESO Registry, 
setting standards of stroke unit care, but 
figures vary from less than 5 in Latvia and 
Croatia, to over 50 in France[228]�
Comparisons of stroke unit care across 
Europe have many caveats because there 
is no Europe-wide standardised system of 
assessment� However, it is clear that stroke 
unit care differs widely between, and within 
countries in terms of both quantity and 
quality�  
the 2015 Helsingborg goals of universal 
availability for every stroke patients have 
not been reached, in most countries by a 
very wide margin. 
example from the uK: Until 2010 acute 
stroke care in London was provided in 32 
acute hospitals of very variable quality, 
even though each hospital had a stroke 
unit. From July 2010, all acute stroke 
patients were taken to one of 8 accredited 
hyperacute stroke units for the initial 2-3 
days. Several hospitals were not accredited 
and ceased providing any stroke care at all. 
Length of stay has fallen by about 4 days 
and thrombolysis rates have risen from 
about 3% to about 12%.[244]
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4.2 Thrombolysis (indicator 7)
The benefit of thrombolytic therapy (“clot 
busting treatment”) for acute ischaemic 
stroke has been well established [255]� All 
EU member states have introduced national 
guidelines for the treatment of acute stroke 
including thrombolysis, often based on 
the guidelines issued by the European 
Stroke Organisation or the American 
Stroke Association� The implementation 
of thrombolysis across Europe since the 
beginning of this century has transformed 
acute stroke care, with stroke becoming a 
treatable condition� One of the main targets 
of most national stroke strategies is to 
reduce the time interval from stroke onset to 
diagnosis in order to increase thrombolysis 
rates�
thrombolysis rates have increased in most 
european and sAFe member countries. 
Some countries with long-running national 
stroke audits showed a two- to four-fold 
increase in thrombolysis rates between 
2004 and 2008, e�g� Germany: 6�0% to 
9�5%, Sweden: 2�2% to 7�0%, and Poland: 
0�9% to 1�2%[163]� UK thrombolysis rates have 
increased from 1�8% in 2008 to 12�2% in 
2014[237]� Israel reported an increase from 
0�4% in 2004 to 5�9% in 2010 in hospitalised 
stroke patients[71]�  
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Figure 10 shows the proportion of thrombolysed ischaemic stroke patients, as reported 
in national or large regional audits, or published national estimates� Studies referring to 
individual hospitals, or stroke unit patients only (e�g� France: 16�7%[241]) were excluded� The 
time point of data collection is included in the figure and explains some of the variations 
found�
Figure 10: thrombolysis rates in national/large regional audits or national estimates in the 
year indicated 
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As with stroke unit care, thrombolysis 
rates vary widely across europe, but are 
generally lower in eastern european 
countries. variations between eastern 
european countries are also large. The 
2015 CEESS Working Group Survey[230] 
published numbers of thrombolysis 
procedures undertaken in Eastern European 
countries between 2008 and 2014� In 
this 7-year period in Romania (22 million 
population) 205 thrombolysis procedures 
were undertaken and 149 in Ukraine (45 
million), compared to 1572 in Estonia (1�3 
million) and 3665 in Slovakia (5 million)� 
Figure 11 presents these figures converted 
into average annual thrombolysis rates per 
100,000 population for easier comparison� 
Both Western (Germany [263,264], 
Netherlands[265], Spain[231], Sweden: 7-fold 
gradient[266]) and eastern european  countries 
have found significant inequalities within 
their countries between different areas and 
particularly also between different centres/
hospitals� 
In Bulgaria, the national rate was below 
1%, but has risen from 0�04% in 2006 to 
0�1% in 2009, with rates being higher in 
urban centres[189, 267], while in Romania in 
2012 thrombolysis was only available in 
Bucharest, the capital covering around 
10% of the population[258]� In Hungary, the 
thrombolysis rate was 3�2% in 2013[213], 
again with significant differences between 
national rates and rates in large cities[258, 268]� 
One Slovakian centre reached thrombolysis 
rates of 15�8% against a national rate of 0�5-
1%[256]� Polish studies reported thrombolysis 
rates of 4�2% in rural areas compared to 
23�1% in urban areas[269] and centre rates 
varying between <3% to around 20%[236] In 
the Czech Republic, the thrombolysis rate 
was 2�5% nationally in 2009, while a group 
of centres (SITS registered) achieved 4�3% 
in 2007[270]�
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Figure 11: Average annual thrombolysis rate per 100,000 population, 2008-2014[230]
Again, comparisons between studies have 
limitations as different studies reporting 
thrombolysis rates often investigate different 
subgroups� Denominator populations vary 
between all stroke patients, all ischaemic 
stroke patients, hospitalised stroke patients 
(e�g� national audits), stroke unit patients (e�g� 
Austrian Stroke Unit Register), or refer to a 
specific region (population-based registers) 
or individual stroke centres only (31% in one 
Finnish centre in Helsinki[210], 22% in 2012 
in large Dutch University hospital[271], 11% in 
University hospital Verona, Italy[193], 0% in 
two Lithuanian centres in 2006/7[272]�
The 2006 Helsingborg Declaration states 
as a goal for 2015 that all countries aim to 
establish a system for the routine collection 
of data needed to evaluate the quality of 
stroke management, including patient safety 
issues� However, national audits are only 
undertaken in a small number of countries 
(chapter 1�1�)�
Standardised, internationally agreed 
datasets would allow accurate international 
benchmarking� The Safe Implementation 
of Thrombolysis in Stroke (SITS) Registry, 
started in 1996, contains standardised data 
on thrombolysis procedures performed 
in each country, but shows significant 
variations between countries in terms 
of the percentage of centres providing 
data (Appendix 1, Table 3)� Due to these 
highly variable recruitment rates SITS data 
is currently a poor measure of national 
thrombolysis rates and country-level 
comparisons�
The international Registry of Stroke Care 
Quality (RES-Q) was launched in May 
2016 by ESO, targeting mainly Eastern 
European countries, but aiming to collate 
internationally agreed care quality 
measures�
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So, due to the variations between studies, 
only rough indications and trends can 
be observed when comparing between 
countries� Data is more reliable when 
looking at trends over time within a 
smaller subgroup (single centre, region, 
hospitalised patients only)�  Observing 
trends over time is a valuable part of stroke 
observational studies, as they provide proof 
that organisational change is efficient� 
Additionally, monitoring performance itself 
helps to improve care quality[163]�
Structural changes to stroke services were found to be associated with higher thrombolysis 
rates in European studies and supported by a recent review[274]: 
hospital pre-notification (Portugal[216]) 
and reduction of door-to-needle time (Netherlands[224])
implementation of stroke unit care (Germany[275],  
Sweden[266]: thrombolysis 5-times more likely in stroke unit)
centralization of stroke services  
(Denmark[250], UK[244]: rise in thrombolysis rate from 3 to 12%)
A further factor that has contributed to 
increased thrombolysis rates was the 
approval of the extended time window for 
thrombolysis from 3 to 4�5 hours by the 
European Medicines Agency in November 
2010� 
A rapid implementation into clinical practice 
was observed leading to an increase 
in thrombolysis rates from 8�6% before 
to 11�7% in a large hospital-based study 
in Germany[276]� Additionally, changes in 
reimbursement systems are also relevant� 
The Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) 
includes over 160,000 stroke patients from over 70 countries, primarily those who received 
thrombolysis. All European countries are registered, but reporting rates vary hugely between 
countries, either due to low thrombolysis volumes, or poor interest in reporting data (19,826 
cases from Czech Republic, 4th largest contributor to SITS), compared to 354 from France, 
2002-2016,[228]. 
The Registry of Stroke Care Quality (RES-Q) is an important project within the European 
Stroke Organisation (ESO) launched in May 2016 and targeted primarily at Eastern European 
countries. It is a multi-national study designed to document the quality of stroke care. 
Standardised measurements have been agreed by an international working group[273] and 
include the availability of stroke units, brain imaging, vascular imaging, cardiac arrhythmia 
detection, thrombolytic therapy, and other factors[228].
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In Poland, thrombolysis was initiated within the Polish National Cardiovascular Disease 
Prevention and Treatment Program POLKARD and was subject to reimbursement limits� Since 
2009 thrombolysis is reimbursed through the National Health Fund with no reimbursement 
limits� Thrombolysis rates increased from 4�3% to 7�6% in a hospital based observational 
study[277]�
despite improvements over the last 
decade, thrombolysis rates are still 
significantly below expectations in europe. 
This is particularly true for Eastern Europe, 
but also for Western European countries� In 
Germany, only 60% of eligible patients were 
found to have received thrombolysis in 
2012[238], and 42% in Italy and Portugal[216, 278]� 
Under-performance was also reported from 
France[212] and the Netherlands (5-7% actual 
rate compared to 25% potential rate[187], 
whereas the National Stroke Audit for 
England, Wales and Northern Ireland 
concluded that 81% of eligible patients were 
thrombolysed in 2014[237]� 
Barriers to the delivery of thrombolysis are 
numerous and complex[279]� 
The most significant barriers include pre- 
and in-hospital delays�  Within pre-hospital 
delays, poor public knowledge as well 
as inadequately trained ambulance staff 
has been identified as significant factor in 
European studies (review[180], Poland[269], 
Sweden, Denmark, and Norway[280], 
Norway[281, 282], England[283], Netherlands[187, 
284, 285])� In-hospital delays were related to 
insufficient in-hospital routines, i�e� the 
existence of and adherence to specific 
protocols[280, 286], a lack of specialised 
units or staff[275, 287, 288], lack of diagnostic 
equipment[228], a de-centralised system 
of stroke care[284] and low thrombolysis 
numbers[223, 289]� Additionally, financial 
considerations are important� In 35% of 
Czech centres thrombolysis was found to 
be restricted due to financial limitations[270], 
and, as above, re-imbursement schemes 
limited thrombolysis in Poland until 2008[277]�
“Treatment with rt-PA in ischemic stroke was introduced … within the frame of the 
Polish Ministry of Health National Cardiovascular Disease Prevention and 
Treatment Program POLKARD. As the funds in POLKARD were limited, the 
number of centres and total number of patients treated with thrombolysis in each 
centre were limited. This resulted in an unusual situation, where legally registered 
treatment could not be administered to all eligible and insured patients. 
Beginning with 2009, thrombolytic treatment in acute stroke has been 
reimbursed by NFZ (National Health Fund, Narodowy Fundusz Zdrowia)… When 
reimbursement limits were eliminated, higher proportion of patients 
with acute ischemic stroke could be treated with intravenous 
thrombolysis …”[277].
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Accordingly, improvements to the factors listed above have been suggested or found to 
improve thrombolysis rates further� 
Thrombectomy (mechanically removing 
blood clots) is currently being introduced in 
many European countries by including it in 
national stroke guidelines and implementing 
the necessary health care facilities in 
specialised centres� While there are several 
countries where it is not yet available at 
all (Bulgaria, Iceland, Macedonia[9, 178]), in 
most countries it is not available 24/7 or in 
all regions� Future effort will be required 
to implement a network of collaborating 
hospitals with regional referral centres that 
makes thrombectomy more widely available 
to patients� 
In summary, thrombolysis rates have 
increased significantly over the last decade� 
However, large variations exist between 
and within countries� Even countries with 
comparatively high thrombolysis rates 
have room for improvement� Apart from 
improving public stroke knowledge, several 
organisational factors have been found to 
improve rates and merit further assessment 
of their effectiveness and feasibility 
according to the individual country’s context�
Accurate international comparisons of 
stroke care quality, e�g� thrombolysis 
rates, are difficult, because of a lack of 
standardised, internationally agreed and 
widely collected quality measures� Within 
the EU, there are numerous stroke registers 
on a local, regional, national, and sometimes 
international level collecting varied data 
with different methods� International stroke 
registers with standardised datasets exist, 
e�g� SITS-MOST and RES-Q (see example), 
but data reporting is voluntary and therefore 
coverage varies significantly�
Public awareness campaigns to reduce 
pre-hospital delay[214]
Ambulance training and hospital pre-notification (UK[290], 
Norway[282], Netherlands[291])
Use of mobile medical teams to bypass emergency room 
admission (France[292], Germany, review[274], review[293])
Improved hospital services and protocols (Netherlands[291], 
Poland[236], review[274])
Treatment by specialised staff / stroke units 
(review[274])
Centralisation of stroke services, primary and comprehensive 
stroke centres to increase volumes (review[293], review[274])
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If used more extensively these registers could contribute to reliable international 
benchmarking, providing valuable insights into inequalities of care and the performance 
of different healthcare systems and helping to focus on areas where improvement is most 
needed�
4.3 Recommendations - Acute stroke care
There are still far too few people across Europe being treated in dedicated stroke 
units with stroke specialist, multidisciplinary staff� Efforts are required, especially in 
Eastern European countries, but also many Western European areas, to increase 
availability of stroke unit care and personnel specialised in stroke care�
Improvement plans should prioritise the consistent implementation of key elements 
of organised stroke unit care, as laid out in ESO and national guidelines�
Comparisons of stroke unit care between European countries are difficult�  
A Europe-wide system of standardised assessment criteria of stroke unit care would 
encourage international benchmarking and could drive quality improvement�
Thrombolysis is still under-performed across all of Europe� Structural changes to 
acute stroke care within the respective national and local context could help to 
improve thrombolysis rates and patient outcomes�
Thrombectomy is currently unavailable to the majority of European stroke patients� 
Organisational changes are required with hospital networks and regional referral 
centres in order to facilitate the implementation of thrombectomy across Europe 
and to make it more widely available�
@Stroke Association
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stroke survivors across europe are waiting too long to have their immediate rehabilitation 
needs assessed and therapies started. In general, the rehabilitation they get is not intense 
enough, is too short, and often fails to address on-going issues, such as depression.  very 
few people get follow up reviews. In the long term, support is too often non-existent.  this 
section looks at what rehabilitation and long-term support is available for stroke survivors 
across europe.
Many stroke patients have problems with 
mobility, fatigue, speech, memory and/
or emotions among others and need 
support from one or more therapy areas 
(such as physiotherapy, speech therapy, 
occupational therapy and/or psychology)� 
These problems affect their ability to 
complete daily activities at home and to 
participate in the community: in England, 
Wales and Northern Ireland, over a third 
(40%) of stroke survivors need help with daily 
activities when they are discharged from 
hospital[294]� Patients should be assessed for 
these problems by therapists while they are 
in hospital and a rehabilitation plan should 
be made� 
Problems related to stroke can be long-
lasting� After 15 years, two-thirds (63%) of 
survivors are living with disability, nearly two 
in five (39%) have depression and over a 
quarter (30%) have cognitive impairment[295]� 
Furthermore, stroke patients are much 
more likely than people who have not had 
a stroke to be living with another illness[296]�
Health and social care services need 
to understand and address gaps in 
rehabilitation and support, as inadequate 
rehabilitation can leave patients with 
disabilities that could have been avoided[297]� 
Stroke patients may find that health and 
social care services do not meet all their 
needs� For example, in one UK study, 
up to 59% of patients reported unmet 
clinical needs[3]� Post-stroke disability 
contributes significantly to long-term 
healthcare resource use, therefore effective 
rehabilitation will potentially save costs[7]�
@lifewithspasticity�com
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5.1 Data on rehabilitation and longer 
term care
In comparison with acute medical care, 
longer-term management and support have 
not been as well researched to identify 
best practice, or to describe what is being 
provided by each health system� The 
information presented here on provision 
of rehabilitation is therefore, for many 
countries, based on our consultation with 
health and research professionals and 
stroke support organisations, and has not 
been verified�
A small minority of countries regularly check 
what rehabilitation is being provided to 
patients in hospital, in at least one region[9] 
(Bulgaria, Catalonia, Czech Republic, 
Germany, Ireland, Slovakia, Sweden, UK)� 
Audits of rehabilitation provision after 
discharge from acute hospital are rarer 
(Ireland, UK)� 
There are ongoing European rehabilitation 
studies which will provide more reliable data 
in the future� These include the ESO project 
Res-Q, which will include a performance 
measure on early rehabilitation assessment 
(led by Czech Republic,[9]); and an ongoing 
study on rehabilitation delivery and 
outcomes in the Netherlands[298]�
Where data is available, it is not necessarily 
possible to compare rehabilitation between 
countries because the studies use different 
definitions of what rehabilitation or a 
particular therapy consists of, and different 
performance measures (e�g� timeframe, 
patient applicability)� For instance, some 
audits include ‘assessment for rehabilitation 
(physiotherapy/occupational therapy)’ as a 
quality indicator (Catalonia, Czech Republic 
Germany, Ireland, Luxembourg, Slovakia, 
Sweden, UK) but there is inconsistency in 
what time period this is recorded for (e�g� 
within 48 hours in Catalonia, within 72 hours 
in UK)[299]�
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5.2 Rehabilitation guidelines
European stroke care guidelines make recommendations for the elements of rehabilitation, 
although there is not enough evidence to be certain about what exactly the therapies should 
consist of, how long sessions should last for and how often patients should have therapy 
sessions or practise themselves� For instance, ESO guidelines (2008)[300] recommend:
5.3 Early coordinated multidisciplinary rehabilitation (indicator 9)
Early rehabilitation improves outcomes for 
stroke patients[301]� Patients who get care 
and rehabilitation in a stroke unit (i�e� a 
multi-disciplinary team of medical, nursing 
and therapy staff who meet at least once 
a week) rather than on a general medical 
hospital ward, are less likely to die and less 
likely to be dependent on other people after 
they leave hospital[226]� 
However, the therapies that patients can 
access often depend on where in a country 
they live (e�g� Belgium[302], Netherlands[9], 
Portugal[303], UK[237])� In some countries, 
specialised neurology/stroke inpatient 
rehabilitation centres have very limited 
capacity or are non-existent (Bulgaria[304]; 
Croatia[305]; Cyprus[306]; Ireland[307], 
Lithuania[308], Poland[308] and Slovakia[9])�
There is wide variation across Europe 
in how well countries meet their targets 
for assessment and rehabilitation� Early 
multidisciplinary assessment is one 
example� In Sweden the national stroke 
audit records whether eligible patients are 
assessed by a multidisciplinary team within 
48 hours of admission� 
“I was six weeks in emergency 
care, nearly six months in total in 
hospital, and afterwards directly in 
rehabilitation. That means I was half a 
year away from home. I continued my 
therapies, my rehabilitation therapies 
over seven years…they kept me too 
long in the hospital because I was a 
private patient. I should have gone 
three months earlier to rehabilitation. 
 I think that would have helped a lot.” 
(Female stroke survivor, 
Austria)
Early, coordinated multidisciplinary rehabilitation (on a stroke unit, for acute patients)� This 
includes physiotherapy, occupational therapy, and communication therapy assessment 
(speech and language)� Individual countries’ national guidelines (where they exist) include 
similar statements�
Early discharge from stroke unit care if medically appropriate and suitable community 
rehabilitation is available
Early assessment of needs after discharge
Rehabilitation after discharge during the first year after stroke�
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This target is met for 78% of patients[309]� In 
contrast, in Ireland, although two thirds of 
applicable patients have a physiotherapy 
assessment within 48 hours of admission, 
less than half of patients have an 
occupational therapy assessment in that 
timeframe[129]� 
Early multidisciplinary therapies in hospitals 
are meant to be standard practice across 
Europe but in some countries access 
is inadequate e�g� Austria,[9]; Finland[310]; 
Ireland[129] or many patients are often not 
treated early enough� For example, in 
one study in Poland about half of patients 
were not seen for rehabilitation within 3 
months[311]� 
Across Europe, access to therapies other 
than physiotherapy can be especially poor� 
For example, in some countries patients do 
not usually get occupational therapy and/or 
psychological therapy� 
This is the case for occupational therapy in 
Bulgaria[9], Croatia[9], Cyprus[306], Italy[244], and 
Slovakia[9]; and for psychological therapies 
in Bulgaria[9], Croatia[9], Czech Republic[9], 
Ireland[312] and the UK[161]�
There is little data collected across Europe 
on how much therapy patients actually get� 
The available data suggests that patients 
get therapies for only brief periods of each 
day in hospital, due to e�g� time pressures 
and staff availability[313, 314]� 
For example, in a Netherlands study (of 
physiotherapists across most acute hospital 
stroke units) patients only had an average 
of 22 minutes per day of exercise therapy 
on weekdays[314]� In the UK during a similar 
time period, patients had physiotherapy on 
only half of the days they were in hospital, 
giving an average per day of stay of under 
15 minutes vs a target of 27 minutes[315] 
(provision in the UK has on average 
improved since then[55])� Some evidence 
suggests that more formal management of 
therapy, for instance having defined phases 
of rehabilitation, can improve provision as 
therapists spend more time with patients 
and less time on nontherapeutic activities[313]�
“I think that receiving psychological 
support, not only for myself but also 
for my family, since the beginning of 
the ‘illness’ would have been very 
positive…It was very difficult to be away 
from my children [while in rehabilitation 
centre] … the fear of dying or being 
stuck in a wheelchair forever …” 
(Female stroke survivor, Portugal)
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5.4 Early supported discharge (indicator 10)
There is an increasing trend to reduce 
the length of time that patients spend in 
hospital� Several countries discharge stroke 
survivors from hospital within 1-2 weeks 
(e�g� Austria, Bulgaria, Estonia, Slovakia[9])� 
However, rehabilitation in the community is 
limited in many countries and people may 
be discharged without follow up support� 
Some countries have developed care 
pathways where mild to moderately 
affected stroke survivors are discharged 
when medically stable, and continue to get 
rehabilitation at home at a similar intensity 
to support on a rehabilitation unit (‘early 
supported discharge’)� 
One third of patients are typically eligible for 
early supported discharge[316]� When these 
early supported discharge services are well 
organised, patients can return home earlier 
and are more likely to regain independence 
in daily activities[316], and there is evidence 
of its cost-effectiveness compared with care 
on the general medical ward or on a stroke 
unit (without early supported discharge)[317]� 
In a few countries, early supported discharge 
is well established, if locally variable, and is 
included in national guidelines i�e� Sweden, 
with an average length of stay of 12 days[318], 
and the UK[319, 320]� In England, Wales and 
Northern Ireland, 81% of hospitals have a 
stroke skilled early supported discharge 
team and 35% of patients are treated by 
one of these teams[294, 321]�
In most European countries, including 
in other high-income countries, early 
supported discharge has not been well 
developed� In around half of EU countries for 
which we have data it is non-existent or not 
nationally developed i�e� there have been 
local trials or pathways but not widespread 
implementation (Appendix 1, Table 4)�
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5.5 Follow up on rehabilitation needs after discharge from hospital (indicator 11)
Problems related to stroke can be long 
lasting but questionnaire responses 
received by King’s College London suggest 
that only around 2 in 5 EU member countries’ 
guidelines recommend (or it is usual practice) 
that patients are offered follow-up reviews 
with a member of the therapy team, doctor/
consultant or stroke service after discharge 
from hospital or rehabilitation centre (Figure 
12)� In nearly 2 in 5 countries, there are no 
formal arrangements for reviews (no known 
local protocols or national guidelines), and 
in a quarter of countries, there are some 
examples of services offering reviews but 
the practice is not thought to be widespread�
Follow-up reviews may be supported in guidelines but not consistently implemented: for 
instance, UK consensus guidelines recommend that patients are offered a structured health 
and social care review at 6 months and 12 months after stroke[322] but the arrangements for 
reviews and who delivers them (e�g� therapist, GP or multidisciplinary team) is very variable 
according to local funding decisions[323]�
Figure 12: Availability of follow-up reviews in eu member countries as percentage 
of 20 countries for which information available (Appendix 1, Table 5)
No formal arrangements Possibly (locally variable) Usual practice / supported in 
guidelines
0%
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15%
20%
25%
30%
35%
40%
45%
“From that point[the stroke] it 
has been a slow rehabilitation. 
I’ve still got consequences; the 
cognitive problems I have. Travel 
is the worst thing in the world. 
Going through an airport blows 
my mind sometimes.” 
(Male stroke survivor, UK)
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5.6 Rehabilitation after discharge from hospital
Around 2 in 5 stroke survivors in the UK are 
discharged from hospital requiring help with 
activities of daily living[237]�  Few countries 
appear to publish data on community 
provision of therapies� It seems that stroke 
rehabilitation for patients once they have 
been discharged from acute care is very 
variable between and within countries, 
including those with the longest histories 
of providing post-stroke rehabilitation� In 
around 2 in 5 EU countries, outpatient 
therapies are not generally available� In the 
recent past, there has been evidence of 
some countries reducing their outpatient 
stroke rehabilitation programmes�
The variation in access between and within 
countries is due to different organisation 
of stroke services, different strategic 
approaches, and different levels of 
resources� 
In some countries, formal pathways 
between different phases of care (acute, 
inpatient rehabilitation, community 
rehabilitation) do not exist, are incomplete, 
are not fully implemented, and/or vary 
between localities (e�g� Austria[209]; Italy[9], 
Latvia[9], Portugal[9], Macedonia[9], Slovakia[9])� 
According to UK guidelines, hospitals 
should work with patients to make a plan 
for rehabilitation after discharge and make 
referrals to other services as needed[322]� 
There should be formalised pathways 
between acute care, primary care and 
rehabilitation services so that stroke 
survivors’ continuing care is well organised, 
but in several countries links between 
rehabilitation and primary care, e�g� general 
practitioners, are weak[244]� Pathways are 
sometimes not fully implemented, so that 
despite efforts to make post-acute care 
more consistent, patients continue to 
experience different levels of access to 
rehabilitation (e�g� the timing of assessments 
after discharge from hospital, or how long 
they have specialist rehabilitation for)[298]� 
 “There are a lot of things that I 
cannot do that I did before. I was 
fond of skiing – I cannot do that. 
I cannot ride a bicycle because I 
have no balance, and things like 
that. You miss it, but after some 
time you get used to it. It’s a new 
life; you have to adjust to what 
you can do.” 
(Male stroke survivor, 
Norway)
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In many countries, there is not enough 
multi-disciplinary therapy provision for 
stroke survivors in the community, and 
access varies between regions. In most 
countries, increasing numbers of survivors 
are discharged from hospital within a matter 
of days but they may not be able to access 
any or all of the therapies they need in 
the community, and may experience long 
delays� 
This can be a nationwide issue e�g� 
general lack of any provision of outpatient 
or domiciliary care in Eastern Europe 
even sometimes when community based 
rehabilitation is the subject of legislation[36, 
308, 325]� There also tends to be regional 
and rural vs urban variation in access to 
community based rehabilitation, e�g� patients 
in some regions of Ireland[312], Portugal[326], 
Sweden[53] and Spain[9] do not have access to 
outpatient and/or domiciliary rehabilitation� 
Europe-wide, this is particularly true of 
occupational therapy (e�g� Ireland[312]; 
Italy[244]; Luxembourg[9]; Spain[9]) and similarly 
vocational rehabilitation (e�g� UK[161]) and 
psychological support (e�g� Ireland[312], 
UK[161])� Lack of capacity for rehabilitation in 
the community can mean stroke survivors 
experience longer stays in hospital or 
rehabilitation centres (e�g� Croatia[9]; Cyprus; 
Czech Republic[9]; Estonia[9]; and Ireland[129])� 
“After I left the rehabilitation 
hospital I was sent home with a 
multidisciplinary team coming 
home to ask whether I needed 
help from them. I got help from an 
occupational therapist for my aids, 
as a walker, handles in the shower 
and a wheelchair and I went for 
many years to a physiotherapist 
to learn how to walk as steady as 
possible.” 
(Female stroke survivor, 
Norway)
“I stayed there [in a rehabilitation unit in the UK] for half a year with training. That 
was very good. It was physical training and mental training, and all the time they 
measured where I was in the training programme and adjusted it all the way. … 
When I got home [to Norway] I didn’t get any therapy. It took me about half a year 
before I could continue with the training, and that was bad because you should 
have continuous training, that is important. Because when you have a break, then 
you have to start at a lower level again and build yourself up, so you lose a lot of 
time by doing that.” 
(Male stroke survivor, Norway)
Example of post-acute case management, 
East Saxony, Germany. This trial (pilot 
phase) placed patients on a standardised 
post-stroke pathway with a certified 
case manager. The pathway comprised 
patient education, quarterly check-ups 
for vascular risk factors and adherence to 
antithrombotic/anticoagulant medication 
in addition to usual care. Compared with 
usual care alone, the intervention was more 
successful in modifying two important 
stroke risk factors; intervention patients 
also reported higher satisfaction with 
their healthcare and quality of life after 12 
months[324].
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5.7 Practical and emotional support for 
stroke survivors & families (indicator 12)
Apart from medical and physical therapy 
needs, stroke survivors and their families 
may face a number of difficulties in life after 
stroke, including emotional or psychological 
problems, extra costs of living (e�g� transport, 
rehabilitation, medications), and difficulties 
with finding suitable work or returning to 
work and therefore loss of earnings�
5.8 Support from health insurers and 
health authorities
From the limited information we have 
identified, health insurers and national 
health authorities rarely offer support with 
adjusting to life after stroke beyond, in some 
cases, loans for home adaptations and aids, 
and financial benefits for those eligible for 
reasons of unemployment, sickness or 
disability� 
Formal care services are funded less in 
central Europe (e�g� Austria, Germany, 
Netherlands, France, Belgium, Czech 
Republic, and Poland) and southern Europe 
(e�g� Spain, Italy and Greece), compared 
with northern Europe (e�g� Denmark, Ireland 
and Sweden)[7]� 
Independent living support for disabled 
people (as a result of stroke or other 
causes) is very wide-ranging across Europe� 
There has been more focus on institutional 
care in some of the newer EU states (e�g� 
Bulgaria, Lithuania, Romania, Slovenia[325])� 
Access to support can be complicated by 
disagreements between health and social 
care bodies over which department is 
responsible for providing rehabilitation, aids 
and so on (e�g� Sweden[327])�
“The worst thing about it at the time 
was that I had no understanding about 
stroke at all. No one had told me, “You 
may feel like this, you may feel like 
that.” No one explained to my partner 
what it was going to be like moving 
forward, what the consequences might 
be, what they might not be.”
(Male stroke survivor, UK)
“[After the stroke] I was not able to 
find the right words. I was not able 
to understand anything, and I was in 
slow motion. … After my stroke I had 
to give up my job [as a teacher of 
Luxembourgish]. … I took five years to 
understand people and to read short 
texts … Apart from my aphasia the 
worst effects are chronic tiredness and 
insomnia.” 
(Female stroke survivor, Luxembourg)
“You don’t want life to change, it’s too 
hard... we could not talk about it and 
each of us kept our painful feelings 
inside. My sister was afraid of him 
when he looked at her… but she was 
only 4 and couldn’t understand “why 
us”. My father stayed along time in 
a training centre and after 6 months 
came home for good. It was very 
difficult, we had to rearrange the 
house, but worse, I did not want my 
friends to come to our house any more 
just because I was ashamed of him.” 
(The daughter of a male stroke 
survivor, France)
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There is some evidence that austerity has 
had an impact on funding of services and 
financial support for disabled people, which 
potentially includes stroke survivors and 
their families[328]� Most European countries 
have cut funding to health care, social care 
and/or to non-governmental organisations 
in the last 5-10 years, with growing inequality 
between rural and urban areas in access to 
services� 
The areas that have been negatively 
affected vary between countries but include: 
vocational rehabilitation and training and 
support for employers of people with 
disabilities; access to personal budgets; 
disability benefits; and help with costs e�g� 
transport[328]� 
Some countries (Bulgaria, Greece, Poland, Romania) have abandoned programmes such 
as plans to move care more into the community� Some countries (Bulgaria, Greece, Italy, 
Hungary, Spain, Portugal and Romania) have re-emphasised that the family has the main 
(social) caring responsibility, before the state� Some have introduced or increased user fees 
for health services or medications (Hungary, Estonia, Portugal, Spain, UK), and made the 
criteria for accessing disability benefits or personal assistance more strict (Greece, Hungary, 
Ireland, Italy, Portugal, Slovenia, Slovakia, Spain, Sweden, UK)[328]� 
There are some examples of follow-up 
support being funded� Social insurance 
institutions in Estonia and Finland offer 
vocationally oriented rehabilitation; 
the Estonian scheme also offers peer 
support[9, 329]� In parts of the UK the Stroke 
Association is commissioned to provide ‘Life 
after Stroke’ services, including practical 
(communication support, return to work etc�) 
and emotional support�  
 “The challenges [for stroke 
survivors and families in Greece] 
are day to day living …. But also, 
it is becoming a viable member 
of society again and I think 
that’s important worldwide, not 
only in [my country] Greece. In 
Greece you do have support, 
but you do have the immediate 
consequences of stroke which are 
quite devastating for everybody.” 
(Stroke clinician and stroke 
support organisation volunteer, 
Greece)
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5.9 Support from stroke support organisations
Stroke support organisations (SSO) are 
usually voluntary sector (non-governmental) 
organisations providing practical, emotional 
and advocacy support for stroke survivors 
and their families and, often, promoting 
stroke prevention awareness and action� 
Their scope sometimes includes other 
conditions such as other forms of acquired 
brain injury or cardiovascular disease� Most 
EU/SAFE member states have a regional 
or national level SSO (in the Faroe Islands, 
there is a disabled people’s organisation 
with an interest in stroke)� The exceptions, as 
far as we are aware from our questionnaire 
and literature searches, are Lithuania, Malta, 
Romania and Slovakia�
Stroke survivors and their families can 
benefit from attending peer support groups, 
in terms of improvements to their sense 
of wellbeing, social isolation and practical 
skills[330]� Some stroke support voluntary 
organisations also offer opportunities 
for stroke survivors to continue with low 
intensity rehabilitation, e�g� exercise groups 
or communication groups� Examples 
from SAFE member countries include the 
Finland Brain Association’s reablement 
training for patients and families[9]; and the 
Neeman Association rehabilitation clubs in 
Israel which support patients to maintain 
rehabilitation gains[331]�
“…what I see from my organisation 
is that people are very lonely 
after they have lost these abilities 
[physical functions]. And maybe 
worse for those who lose the 
ability to speak, they get very 
lonely; they often get very 
depressed... The families are very, 
very tired. I often speak to the 
relatives, to the families, because 
they don’t know what to do” 
(Volunteer at support organisation 
for people with disabilities 
including as a result of stroke, 
Faroe Islands)
“Eventually I managed to get 
into a [peer support group]. Even 
walking through the door, in the 
end it took my sons to actually 
physically walk me through the 
door because I couldn’t do it 
myself, I just couldn’t face it. I 
didn’t know why. And then when I 
got in there it was suddenly relief. 
They are my stroke family and 
that is what we now call – all of 
us, it is our stroke family.” 
(Male stroke survivor, UK)
@King’s College London Stroke Research Patients and Family Group
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5.10 Recommendations - rehabilitation and longer-term support
Too many stroke survivors have to wait too long to get an assessment of their rehabilitation 
needs and to actually receive therapy� Across Europe the aim should be for multi-disciplinary 
assessments to take place on the stroke unit, and for rehabilitation to start as soon as 
someone is medically stable�
Access to rehabilitation therapy must be improved�  There is a particular lack of occupational, 
speech and psychological therapy across Europe�
Too many stroke survivors leave hospital without on-going rehabilitation being in place� 
This is of particular concern for Early Supported Discharge (ESD) schemes� The evidence is 
clear that the effectiveness of ESD schemes relies upon access to rehabilitation at the same 
intensity as would have been provided on the stroke unit�  
Ongoing, long-term support and follow up is inadequate in many parts of Europe�  We call 
for national systems to be developed to ensure stroke survivors’ needs are reviewed and 
followed up�
Countries should set targets for secondary prevention, screening for depression, and for 
psychological and social support�
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Appendices
1. data tables
table 1: risk factor prevalence in stroke patients, organised by type of source (population-
based study, national hospital-based, regional hospital-based)
Source Country/Region/City Hypertension AF Cholesterol
Population-based registers, 
EROS, risk factors 
diagnosed pre-stroke[10, 41, 105]
France/Dijon 65�2 21�2 28�7
Italy/Sesto Fiorentino 62�1 18�6
Lithuania/Kaunas 67�3 25�4
spain/Menorca 54�0 13�2
uK/London 64�7 15�0 24%
Poland/Warsaw 75�8 25�0
Summary of Italian 
registers[128] 
Italy 54-65 12-24 7-24
Population-based 
register[217]
spain/Catalonia 68�8 18�9
Population-based 
register[332] 
spain/Barcelona 60�6 29�3 19�4
Population-based register, 
ischaemic stroke[36] 
estonia/Tartu 61 30
Population-based 
register[333] 
Greece/Arcadia (♂, ♀) 78/85 31/38 41/46
National population-
based, ischaemic stroke/
intracerebral haemorrhage[16] 
Iceland 29/18
National hospital-based 
data[129] 
Ireland 58�6 24�3 24�5
National hospital-based 
data[309] 
sweden 58�7-65�1 28�1-
28�9
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table 1: continued
Source Country/Region/City Hypertension AF Cholesterol
National hospital-based 
data[54] 
Finland 60 14
National hospital-based 
data[238] 
Germany 80�5 25�6
National hospital-based 
data[71] 
Israel 78�2 17�4 72�9
National hospital-based 
data, EuroHOPE, ischaemic 
stroke only[246] 
Finland 70�9 9�1
Hungary 76�5 4�5
Italy 65�4 3�7
the netherlands 77�2 2�7
sweden 70�3 9�0
Cross-sectional, 
multi-centre survey, 
EUROASPIRE III, stroke-
specific module, ischaemic 
stroke only[115]  
Germany 56�6 74�8
Czech republic 67�3 76�4
Poland 63�6 78�0
Croatia 64�9 72�1
Register of thrombolysed 
patients, SITS-EAST[223] 
Harsany 2014
Croatia, Czech 
republic, estonia, 
Hungary, Lithuania, 
Poland, slovakia, 
slovenia, turkey
75 29 37
Hospital-based study, 
ischaemic stroke[334] 
Lithuania/Vilnius (♂, ♀) 32�1/ 
28�6
Hospital-based study[52] Hungary/Debrecen 81 14�1
Hospital-based study[335] Malta 73�2 9�8
Hospital-based study[281] norway 72�1 31�0 55�9
Hospital-based study[131] norway 32
Hospital-based study[336] Greece/Athens 70�2 31�1 31�5
IS patients admitted to SU 
[337] 
Austria (♂, ♀) 79�1/80�8 22�7/ 
32�3
57�4/51�3
Population-based study[338] denmark 12�5
Primary care data-base[106] uK 65 11 38�7
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table 2: european AF prevalence studies
Belgium 
screening study: 1�4%, 66% of cases previously unknown[95]
Denmark 
2�0% in adults ≥25 years[338]
France 
screening study: 0�05%/0�01% in ♂/♀ ≤50 years compared to 6�5%/5�2% 
in ♂/♀ ≥80[339], prevalence estimate 600,000 to 1 million[340]
Germany
5�3% of patients without previously known AF diagnosed in those with 
additional vascular risk factors� 3% in those with one RF, 7% in those with 
two risk factors[341]
Greece 
screening study in adults>65 years: 5%, increasing with age[150], 3�9%[151]
Iceland 
known AF: 1�9% in 2008, was 1�6% in 1998, projected 3�5% in 2050[134]
Italy
known AF: 1�3%[152]
Netherlands
overall 1�6% , but 7�7% in adults >55, 0�7% in adults 55-59 compared to 
17�8% in adults >85 years[117, 133]
6% annual increase in incidence 1982-2000 and 1�4% annual increase 
2000-2012[342]
Portugal
known AF: 1�29% in adults >30[343], screening study: 2�5% in adults > 40 
(only 1�6% had previously known AF)[123]
Spain
4�4% in adults >40, in 10% of them AF was unknown[125], estimated 
prevalence 1 million, 100,000 unidentified[344], 20�1% of undiagnosed AF 
in population-based study of adults >60 years[154], overall prevalence 
1�5%, steep rise with age: 0�05% in < 45 years, 6�3% in >75 years[345]
Sweden
known AF: 2�9%[155], known AF in adults >20: 3�2%[346]
UK
known AF 1�49%/1�29% in men/women in 2003, compared to 
0�84%/0�83% in 1994 [156], estimate of total prevalence (known and 
unknown): 2�4% or 1�36 million people with 474,000 people being 
undiagnosed (Public Health England, www�ncvin�org�uk)
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table 3: sIts registry, overall figures for EU or SAFE countries, December 2002 to November 
2016[347], ranked by recruitment per 100,000 population
Country
Recruitment 
overall
Recruitment 
per 100,000 
population
Thrombectomy 
Register
General 
stroke 
register
estonia 2660 205�5 147
Czech republic 19826 185�7 595 418
sweden 9269 97�4 363 1267
slovenia 1482 72�3 21
Finland 3667 67�8 334
slovakia 3641 67�1 281
Italy 31349 51�7 725 1362
Lithuania 1395 48�4 126
denmark 2375 44�2
norway 2072 41�2 22
Portugal 3844 36�2 293
Bulgaria 2692 35�3 2180
uK 22884 34�9 363
Croatia 1387 30�9 1
Belgium 3073 27�9 206 413
Hungary 1926 19�1 21
Austria 1146 14�0
Poland 4861 12�6 68
spain 4138 8�8 270
Germany 6637 8�1 73
Macedonia 165 8�0
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table 3:  continued
Country
Recruitment 
overall
Recruitment 
per 100,000 
population
Thrombectomy 
Register
General 
stroke 
register
Greece 468 4�0 6
Israel 255 3�1
Iceland 8 2�5
netherlands 217 1�3
Ireland 57 1�2
France 354 0�6
ukraine 27 0�1
Cyprus 0 0�0
Latvia 0 0�0
Luxembourg 0 0�0
Malta 0 0�0
romania 0 0�0
serbia 0 0�0
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table 4: early discharge practices in eu countries (ESD = early supported discharge)
EU Country
Typical availability of early discharge to further 
rehabilitation
Source
Austria Early discharge to inpatient rehab centre [9]
Belgium Not generally available [9]
Bulgaria Not generally available [9]
Croatia Not generally available [9]
Czech 
republic
Not generally available [9]
Cyprus Not generally available [348]
denmark Early discharge to inpatient rehab centre /community as 
appropriate  (ESD available in one region)
[250]
estonia Not generally available [9]
Finland Early discharge to inpatient rehab centre /community as 
appropriate 
[9]
France Not generally available [9]
Germany Early discharge to inpatient rehab centre [9]
Greece Not generally available [9]
Ireland Early discharge to inpatient rehab centre /community as 
appropriate  (ESD available in some regions)
[129]
Italy Early discharge to inpatient rehab centre /community as 
appropriate  (ESD available in some regions)
[349]
Latvia Not generally available [350]
Lithuania Not generally available [244]
Malta Not generally available [9]
netherlands Early discharge to inpatient rehab centre /community as 
appropriate (ESD available in at least one region)
[351]
Poland Not generally available [311]
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table 4:  continued
EU Country
Typical availability of early discharge to 
further rehabilitation
Source
Portugal Not generally available [326]
slovakia Not generally available [9]
slovenia Not generally available [9]
spain Not generally available [244]
sweden Early discharge to inpatient rehab centre /community as 
appropriate (ESD available in some regions)
[9]
uK Early discharge to inpatient rehab centre /community as 
appropriate (ESD available in majority of regions)
[55]
Hungary
Luxembourg
romania
No data found
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table 5: Follow up review practices in eu countries. Sources:[9, 323, 352]
EU country Follow up review practice
Austria Possibly, depending on local practice - no specified timescale
Belgium Possibly, depending on local practice - no specified timescale
Bulgaria No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
Croatia No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
Czech republic No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
Finland National guidelines support reviews/usual practice - 0-3 months after 
discharge
France National guidelines support reviews/usual practice - >3-6 months after 
discharge
Germany Possibly, depending on local practice - no specified timescale
Greece No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
Ireland National guidelines support reviews/usual practice - >3-6 months after 
discharge
Italy National guidelines support reviews/usual practice - 0-3 months after 
discharge
Latvia No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
Luxembourg National guidelines support reviews/usual practice - no specified 
timescale
Malta National guidelines support reviews/usual practice - no specified 
timescale
netherlands Possibly, depending on local practice - no specified timescale
slovakia No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
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table 5:  continued
EU country Follow up review practice
slovenia No formal arrangements for follow-up reviews (other than e.g. SITS/
research follow ups)
spain Possibly, depending on local practice - no specified timescale
sweden National guidelines support reviews/usual practice - no specified 
timescale
uK National guidelines support reviews/usual practice - >3-6 months after 
discharge
Cyprus
denmark
estonia
Hungary
Lithuania
Poland
Portugal
romania
No data found
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2. research framework and methods 
used in the study
2.1 Development of stroke care quality indicators
To select the 12 care quality indicators to be included in the study, stroke care guidelines 
and indicators developed by a number of European and international organisations 
were searched  (including from UK Stroke Sentinel National Audit Programme (SSNAP)
[353], UK National Institute for Health and Care Excellence (NICE)[320], UK Royal College of 
Physicians[322], American Heart/Stroke Association[354], European Stroke Organisation[300], 
European Implementation Score Collaboration[355], and Stroke Unit Trialists’ Collaboration[226])� 
A long list of indicators was drawn up based on clinical relevance, likely data availability 
and relevance to SAFE’s objectives, in consultation with colleagues experienced in stroke 
treatment and rehabilitation, and the final 12 indicators were selected in consultation with 
SAFE� These indicators have informed focused literature searching and the development of 
the questionnaire that King’s College London (KCL) sent to country representatives�
table 6. selected stroke care quality indicators
Indicator Source* (evidence base)
PRIMARY PREVENTION
1� Campaigns to encourage healthy lifestyles 
(e�g� blood pressure and cholesterol 
awareness and monitoring)
EIS (consensus)
2� Blood pressure is checked regularly and 
treated according to guideline 
AHA/ASA, NICE CG127 (high/moderate 
quality evidence: observational & 
RCTs**, except for patients aged <40)�
3� Adults with atrial fibrillation at increased 
risk of stroke are treated appropriately 
with anticoagulants 
NICE QS93 based on NICE CG180 (high/
moderate quality RCT evidence), ESO 
2008
EMERGENCY RESPONSE
4� Public campaigns and professional 
education emphasise that stroke is a 
medical emergency
ESO, NCG (consensus)
5� Emergency services (ambulance) staff are 
trained to screen patients for suspected 
stroke/TIA and arrange immediate transfer 
to hospital
ESO, NCG, NICE QS2 (consensus)
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table 6:  continued
Indicator Source* (evidence base)
ACUTE MANAGEMENT
6� In-hospital services offer organised stroke 
care (stroke unit care)
ESO, NCG (consensus)
7� Patients are assessed for thrombolysis and 
receive it (if clinically indicated) as soon as 
possible after the start of stroke symptoms
ESO, NCG[ESO: within 3 hours� NCG: 
all patients within 3 hours if not 
contraindicated; between 3 and 4�5 hrs 
if age<80 and not contraindicated] (high 
quality RCT evidence for benefit up to 
4.5hrs with most benefit up to 3hrs)
Transient Ischaemic Attack (TIA)
8� Patients with suspected TIA are urgently 
assessed for subsequent stroke risk
NICE CG68[assessment within 24 hours 
of onset] (consensus), NCG, ESO
REHABILITATION (ACUTE PHASE)
9� Patients are assessed for rehabilitation 
needs within the first three days after 
admission and provided with rehabilitation 
by multidisciplinary staff on the basis of 
need
NCG[assessment by nursing staff + at 
least 1 member of rehab team within 24 
hrs; all relevant members of rehab team 
within 72 hrs]; NICE CG162 (consensus); 
ESO
10� Early discharge from acute care (to 
inpatient rehabilitation unit or to 
community) is supported for medically 
stable patients with mild or moderate 
impairment
ESO, NCG, NICE CG162 (moderate 
evidence for reduced length of stay & 
equivalent outcomes)
FOLLOW UP / POST-ACUTE REHABILITATION 
11� Patients are offered a review after the 
stroke for assessment of medical and 
rehabilitation needs
NCG, NICE QS2, NICE CG162 
(consensus on 6 month review)
12� Patients and their family/carers have 
access to practical and emotional support
NCG (consensus)
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*AHA/ASA= Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare 
Professionals From the American Heart Association/American Stroke Association 2014
EIS= Methods of Implementation of Evidence-Based Stroke Care in Europe, European 
Implementation Score Collaboration 2015
ESO= European Stroke Organisation Guidelines for Management of Ischaemic Stroke and 
Transient Ischaemic Attack 2008 
NCG= National Clinical Guideline for Stroke 5th Edn, Royal College of Physicians 2016
NICE CG68= Stroke and transient ischaemic attack in over 16s: diagnosis and initial 
management Clinical guideline[CG68] National Institute for Health and Care Excellence 2008
NICE CG127= Hypertension in adults: diagnosis and management Clinical guideline[CG127] 
National Institute for Health and Care Excellence 2011
NICE CG162= Stroke rehabilitation in adults Clinical guideline[CG162] National Institute for 
Health and Care Excellence 2013 
NICE CG180= Atrial fibrillation: management Clinical Guideline[CG180] National Institute for 
Health and Care Excellence 2014
NICE QS2= Stroke in adults Quality standard[QS2] National Institute for Health and Care 
Excellence 2010
NICE QS93= Atrial fibrillation Quality standard[QS93] National Institute for Health and Care 
Excellence 2015
**RCT = randomised controlled trial (the ‘gold standard’ of evidence)
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2.2 Literature reviews
A review of the literature on topics in the tender document and on the stroke care quality 
indicators was undertaken� This aimed to establish the best-available information and data 
(most recent and most robust) for individual countries and regions�  The search strategy is 
outlined below�
search terms: Stroke, cerebrovascular accident, CVA, cerebral infarct/infarction  +/- country 
or region name + keyword or combination of keywords of interest of respective chapter
Epidemiology: incidence, prevalence, fatality, burden, epidemiology, epidemiological, 
attack rates, survey, surveillance, projection, trend, audit, register/registry
Prevention: guideline, prevention, preventive, hypertension, hypertensive, blood 
pressure, risk factor, atrial fibrillation, AF, TIA, transient ischaemic attack, mini-stroke
Stroke awareness/ emergency care: emergency, ambulance, pre-hospital, admission, 
arrival, presentation, delay, symptoms, warning signs, knowledge, recognition, 
awareness, education
Acute treatment: stroke unit, care, treatment, thrombolysis, thrombolytic, 
thrombectomy, telemedicine
Rehabilitation and long-term support: discharge, early supported discharge, follow-up, 
physiotherapy, post-stroke, rehabilitation, support, therapy
date range: 2007-2016� Focus on material published since the last Burden of Stroke report 
(2007) but extended to include material published prior to 2007 when information for a 
country was otherwise lacking�
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sources:
Peer-reviewed journal articles (using databases PubMed and Scopus, and searching 
key journals) and their reference lists
‘Grey literature’ such as government/health authority/stroke organisation policies and 
guidelines
Key papers known to research team and SAFE 
Websites (ESO, WHO, OECD, European Observatory on Health Systems and Policies, 
national professional and patient organisations)
Language of search terms and publications: English� The literature identified was mainly in 
English (if an English-language translation of e�g� the webpage was available, this was used)� 
Where key papers were identified by SAFE and were not in English, their members’ help was 
sought to provide brief summary translations�
2.3 Questionnaire and consultation with country clinicians, 
researchers and support organisation representatives
A questionnaire was developed to obtain information and perspectives on stroke care in 
each EU country, additional to information obtained through the literature review process� 
Potential respondents to KCL’s questionnaire were identified through KCL’s & SAFE’s previous 
European stroke research collaborations and through relevant publications� These included 
epidemiologists, neurologists, rehabilitation experts and leaders of national stroke or 
neurology professional organisations� Those contacted were emailed the questionnaire as 
an attachment and were encouraged to name an alternative respondent where appropriate� 
Contacts who did not respond were sent email reminders�
Additionally, the research team gained information and contacts from questions sent by 
the Stroke Association to SAFE board members, from brief discussions with a number of 
clinicians and researchers attending the European Stroke Organisation Conference in 
Barcelona in May 2016, and from discussions with delegates at the SAFE working conference 
in Amsterdam in December 2016�
Not all country contacts responded to the questionnaire� No response was received from 
Cyprus, Denmark, Ireland, Lithuania, Poland, Portugal or Romania� No contact was identified 
for Ukraine�
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table 7. respondents to King’s College London’s questionnaire on stroke care
Country Respondent(s)
Austria Dr Milan Vosko, FESO, Neurologist, Linz
Belgium Dr Robin Lemmen, Neurologist, UZ Leuven
Bulgaria Assoc� Prof� Dr� Silva Andonova, St� Marina University Hospital in Varna, 
head of the Stroke Section at the Bulgarian Society of Neurosonology 
and Cerebral Hemodynamics� Involved in SITS-EAST
Croatia Dr Branko Malojcic, Dpt� of Neurology, University Hospital Center Zagreb
Czech 
republic
Svatava Kalna (with support of Veronika Svobodová), Study Coordinator 
Stroke Research Program  St� Anne’s University Hospital,  Brno 
International Clinical Research Center  
estonia Assoc Prof Janika Kõrv, neurologist, University of Tartu, Estonia
Finland Dr Tiina Sairanen, Department of Neurology, Helsinki University Central 
Hospital
France Professor Maurice Giroud, Dijon Stroke Registry, University Hospital 
of Dijon, University of Burgundy, responsible for the Burgundy Stroke 
Network� 
Professor Yannick Béjot, Dijon Stroke Registry, Head of the Stroke Unit, 
University Hospital of Dijon, University of Burgundy�
Germany Professor Peter Heuschmann, MD, Dr Silke Wiedmann, PhD (1); Professor 
Peter Hermanek, MD (2), Professor Otto Busse, MD (3)� 
Profession/Affiliation: University of Wuerzburg Institute of Clinical 
Epidemiology and Biometry Wuerzburg (1), Bavarian Permanent Working 
Party for Quality Assurance (BAQ), Munich (2); German Stroke Society (3)
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table 7:  continued
Country Respondent(s)
Greece Dr� Konstantinos Vadikolias, MD, President of the Board of Directors 
of the HNS and HSCVD, member of the exec committee of the H�A�S, 
Hellenic Neurological Society & Hellenic Society of Cerebrovascular 
Diseases (Greek Stroke Society) with the collaboration of members of the 
Board of Directors and Committees of the Hellenic Alliance-Action for 
Stroke (H.A.S), Hellenic Neurological Society (HNS) and Hellenic Society 
of Cerebrovascular Diseases (HSCVD) :
Georgios Tsivgoulis, Associate Professor of Neurology, Attikon Hospital, 
University of Athens, Gen Secretary of HSCVD 
Hariklia Proios, PhD, CCC-SLP, Assist� Professor, Department of 
Educational and Social Policy, University of Macedonia, Thessaloniki 
Member of the exec committee of the Board of Directors of H�A�S 
Athina Mitsoglou, Neurologist, General Hospital of Xanthi, member of the 
Board of Directors of the H�A�S 
Dimitrios Keramefs, Member of the Board of Directors of the H�A�S 
Artemis Nikolaos, Emeritus Professor of Neurology, Emeritus President of 
the HSCVD, past President of the HNS, member of the exec committee of 
the H�A�S
Italy Antonio Di Carlo, MD; Institute of Neuroscience, Italian National Research 
Council
Domenico Inzitari, MD; NEUROFARBA Department, University of Florence
Latvia Guna Bērziņa, Physical and Rehabilitation doctor Department of 
Rehabilitation, Riga Stradiņš University 
Luxembourg Prof� Dr� Dirk W� Droste, FESO, Adjunct Professor of Neurology, 
Westfälische Wilhelms-Universität Münster
Malta Johanna Pizzuto, Rehabilitation Nurse, Mater Dei hospital
slovakia Prof� Zuzana Gdovinová, Head of Department, Department of Neurology, 
P�J� Safarik University Košice
slovenia Janja Pretnar Oblak, MD, PhD, Head of Vascular Neurology Dpt, 
University Medical Centre Ljubljana, Slovenia
sweden Kjell Asplund, Professor, MD, Department of Public Health and Clinical 
Medicine, Umea, Sweden
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table 8. respondents to stroke Association questions on stroke care
Country SAFE / nominated respondent(s)
Austria Manuela Messmer-Wullen, President Schlaganfall-Hilfe Österreich (Stroke 
patient organisation)
Belgium Dr Andre Peeters, Belgian Stroke Council
Croatia Dr Hrvoje Budincevic, Croatian Stroke Society
Finland Paivi Seppa-Lassila, Aivoliitto (Finnish Brain Association) and Dr Risto O� 
Roine, Professor and Chairman, Division of Clinical Neurosciences Turku
Germany Dr Markus Wagner, Stiftung Deutsche Schlaganfall-Hilfe, Vice President of 
SAFE
Greece Dr� Konstantinos Vadikolias, MD, President of the Board of Directors of the 
HNS and HSCVD, member of the exec committee of the H�A�S, Hellenic 
Neurological Society & Hellenic Society of Cerebrovascular Diseases 
(Greek Stroke Society) 
with the collaboration of members of the Board of Directors and 
Committees of the Hellenic Alliance-Action for Stroke (H.A.S), Hellenic 
Neurological Society (HNS) and Hellenic Society of Cerebrovascular 
Diseases (HSCVD): 
Georgios Tsivgoulis, Associate Professor of Neurology, Attikon Hospital, 
University of Athens, Gen Secretary of HSCVD  
Hariklia Proios, PhD, CCC-SLP, Assist Professor, Department of 
Educational and Social Policy, University of Macedonia, Thessaloniki 
Member of the exec committee of the Board of Directors of H�A�S  
Athina Mitsoglou, Neurologist, General Hospital of Xanthi, member of the 
Board of Directors of the H�A�S
Greece
(continued)
Dimitrios Keramefs, Member of the Board of Directors of the H�A�S  
Artemis Nikolaos, Emeritus Professor of Neurology, Emeritus President of 
the HSCVD, past President of the HNS, member of the exec committee of 
the H�A�S
Hungary Krisztina Völgyes, National Stroke League of Hungary
Iceland Valgerður Gunnarsdóttir, Ministry of Welfare
Israel Sandra Levy, Neeman Association stroke support organisation
Italy Dr Francesca R Pezzella, A�L�I�Ce Italia stroke patient organisation
Luxembourg Chantal Keller, Bletz asbl stroke support organisation
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table 8:  continued
Country SAFE / nominated respondent(s)
Macedonia Dr Maja Bozinovska, neurologist, president of Macedonian stroke patient 
organisation
netherlands Lineke Dijkstra, Hersenletsel (Netherlands acquired brain injury support 
organisation)
norway Bent Indredavik, Professor Department of Neuromedicine and Movement 
Science, Norwegian University of Science and Technology
serbia Ivan Milojevic , Serbian Stroke Association
slovenia Dr Janja Pretnar Oblak, Head of Vascular Neurology Dept, University 
Medical Centre Ljubljana
spain 
(Catalonia)
Miquel Gallofré  Director Stroke Programme, Health Department, 
Autonomous Government of Catalonia
spain Carmen Aleix, Federación Española de Ictus (Spanish Stroke Federation)
uK Professor Anthony Rudd, National Clinical Director for Stroke, Consultant 
Stroke Physician, Guy’s and St Thomas’ NHS Foundation Trust
